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Intelligence is the ability to adapt to change.  
-Stephen Hawking
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Bien qu’il soit évident que l’étape de transcription régule directement l’expression 
des gènes, comment l’élongation de la transcription régule cette dernière reste encore 
méconnue. Des évidences montrent en effet que certains facteurs de transcription mutés 
influent sur l’élongation de la transcription et mènent à la surexpression de certains gènes, et 
dans un cas extrême, d’oncogènes dans un contexte de cancer. Mais que se passe-t-il si le 
problème est pris à l’envers ? C’est-à-dire, si la cinétique d’élongation de la transcription est 
ralentie, quelles sont les conséquences sur l’expression génique ? 
 
Pour ce faire, nous utilisons l’édition génomique CRISPR-cas9 chez 
Schizosaccharomyces pombe afin de générer un mutant Rpb1 qui produit un complexe ARN 
polymerase II dont la cinétique d’élongation de la transcription est plus lente qu’une souche 
sauvage. 
 
L’analyse de gènes différentiellement exprimés par RNA-seq nous a permis 
l’identification de gènes significativement sur-exprimés en réponse à différents stress et de 
gènes significativement sous-exprimés en lien avec les ARN non-codants. De plus, en 
combinant ces données avec une cartographie publiée des sites de polyadénylation alternatifs, 
il a été possible d’observer un usage accentué et significatif des sites de polyadénylation 
proximaux dans le mutant « slow ». Ensemble, ces résultats suggèrent l’étude du gène tgp1 
codant pour un transporteur transmembranaire de phosphate et qui est régulé en cis par un 
ARN non-codant long. Des expériences de ChIP-qPCR ont permis de rassembler des indices 
mécanistiques sur le lien entre une vitesse d’élongation lente et la sur-expression de tgp1. 
 
 
Mots clés : Schizosaccharomyces pombe, expression génique, cinétique d’élongation 
transcriptionnelle, Rpb1, nc-tgp1, tgp1, polyadénylation alternative, terminaison 
transcriptionnelle. 
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Although it has become clear that transcription is intimately coupled to gene 
expression, how transcription elongation influences the transcriptome remains poorly 
understood. Some studies have shown that mutations in particular transcription factors 
impact transcription elongation leading to the potential overexpression of some genes, and 
in extreme situations, oncogenes which are associated with cancer. However, what if we 
approached this problem another way? How would gene expression be affected if 
transcription elongation rate was slowing down? 
 
To examine those consequences, we used genome editing in the fission yeast 
Schizosaccharomyces pombe to generate rpb1 mutants that produce a RNA polymerase II 
complex that transcribes slower than the wild type RNAPII. 
 
Using RNA-seq, differential gene expression analysis revealed a list of genes 
significantly up-regulated in conjunction with stress responses and a list of genes 
significantly down-regulated in conjunction with non-coding RNAs. Moreover, after 
merging those data with published genome-wide alternative polyadenylation sites, we 
discovered a more efficient function of the proximal polyadenylation sites in the slow mutant. 
Together, these results suggest a focus on tgp1 whose protein product is a phosphate 
transmembrane transporter, and which is known to be regulated by a cis long non-coding 
RNA. Several ChIP-qPCR assays have allowed us to gather mechanistic evidence about the 
link between a slow transcription elongation rate and tgp1 overexpression. 
 
Keywords: Schizosaccharomyces pombe, gene expression, transcription elongation rate, 
Rpb1, nc-tgp1, tgp1, alternative polyadenylation, transcription termination 
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Introduction 
1. Schizosaccharomyces pombe: A Key Model Organism 
The fission yeast Schizosaccharomyces pombe is an important model organism for 
the study of eukaryotic molecular and cellular biology. On one hand it is a unicellular 
organism, sharing many useful features with the first and well-known model organism for 
molecular biology, Escherichia coli. Since both are microorganisms, it is easy to reach 
extremely large numbers of cells allowing quick and substantial coverage in a single 
experiment. They can also maintain autonomous plasmids that reversibly introduce genetic 
material to modify the behavior of a strain, and pairing that with their highly active 
homologous recombination mechanisms makes S. pombe a user-friendly tool for genetic 
manipulation for the discovery of genes involved in a given biological process (Orr-Weaver 
et al., 1981). On the other hand, it is a eukaryotic organism. In that way it provides important 
insights of conserved processes in humans which directly helps experiments in more 
complicated cell types (Hoffman et al., 2015). 
Most people are familiar with brewer's or baker's yeast, Saccharomyces cerevisiae, 
which is a popular laboratory yeast model system, as well as the "Yeast infections" from 
Candida albicans. However, the fission yeast S. pombe is a very different organism because 
it has diverged from the ascomycete lineage before S. cerevisiae (Heckman et al., 2001). In 
other words, S. pombe has undergone fewer evolutionary changes since divergence from the 
common ancestor, leading to the retention of more characteristics with the common ancient 
yeast ancestor and, by association, more features with humans (Aravind et al., 2000; Wood, 
2006). For example, S. cerevisiae has lost 300 more genes than S. pombe compared to the 
common ancestor (Aravind et al., 2000) resulting in an increased number of homologous 
genes between the fission yeast and human. Furthermore, the genome of S. pombe has 43% 
of genes with introns (Wood et al., 2002) which, according to this feature, puts the fission 
yeast equidistant between S. cerevisiae with around 4% of genes with introns (Lopez and 
Séraphin, 1999) and human with 97% of genes with introns (Grzybowska, 2012). Briefly, S. 
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pombe has become one of the two major yeast model systems, together with S. cerevisiae, 
providing important insights regarding cell cycle, chromosome dynamics and gene 
expression (Hoffman et al., 2015). The outcome of its rise in popularity as a research 
organism was the creation of a comprehensive database for the fission yeast called Pombase 
(Wood et al., 2012) providing structural and functional annotation, literature curation and 
access to large-scale data sets, as well as the website PombeNet offering more practical 
advices for working with fission yeast. 
2. Gene expression (coding versus noncoding transcription units) 
The information database of a cell is encoded in DNA subunits called genes. Gene 
expression refers to a complex series of processes in which the information encoded in a gene 
is used to produce a functional biochemical product. There are two categories of genes in 
every organism: the coding genes where the final product is a protein, and the non-coding 
genes, which do not provide instructions for making proteins.  
Gene regulation is a multilayer process by which, depending on the needs of the cell, 
a gene can be tuned at each step from DNA to RNA to protein providing the cell checkpoints 
for self-regulating its functions to adjust the amount and type of proteins it manufactures. 
Both coding and non-coding genes must undergo the very first step of gene expression called 
transcription. Even though the final product is completely different for a coding or non-
coding gene, and is obtained from potentially three different enzymes, they still share 
common mechanism of transcription termination in the fission yeast (Larochelle et al., 2018). 
2.1. The transcription process (initiation, elongation, and termination) 
 In order to read the information encoded in genes, every living organism has to deal 
with the transcription step. The DNA-directed enzyme, RNA polymerase, is the main 
component of this process. It is subject to regulatory control at all stages of the transcription 
cycle, including initiation, elongation and termination. 
During the first stage of initiation, the polymerase is recruited to a gene promoter, 
sometimes with the help of a transcriptional activator binding upstream from the promoter 
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(Blackwood and Kadonaga, 1998) or sometimes because of the absence of a transcription 
repressor and its steric hindrance (Hanna-Rose and Hansen, 1996). The DNA double helix is 
unwound to expose the template single strand, the first few nucleotides of RNA are 
synthesized and then the polymerase pauses in early transcriptional elongation, between 30 
and 60 nucleotides downstream of the transcription start site (Kwak and Lis, 2013). The 
paused polymerase remains stably associated with the nascent RNA and is fully capable of 
resuming elongation, however further signals are required to elicit the transition to a 
productive elongation complex (Adelman and Lis, 2012). Once this maturation is reached, 
the enzyme escapes from the promoter to enter a phase of productive elongation (Juven-
Gershon and Kadonaga, 2010). 
The elongation step involves the complimentary copy of a single strand template of 
DNA into RNA composed of ribonucleotides including uracil where thymine occurred in the 
DNA sequence. Interestingly, promoter clearance is more complex than initially thought 
(Sims et al., 2004). Multiple factors can modulate elongation rates between genes or within 
the same gene from ∼1 to 6 kilobases (kb) per minute (Jonkers and Lis, 2015). Those factors 
include histone marks and gene features such as the number of exons. It suggests that 
elongation rate plays an important role in co-transcriptional processes such as splicing and 
transcription termination (Alexander et al., 2010; Jonkers et al., 2014; Veloso et al., 2014). 
Finally, the end of the transcription unit is delimited by transcription termination 
when the polymerase and the nascent RNA are released from the DNA template (Richard 
and Manley, 2009). In that way, it prevents the polymerase from interfering with downstream 
DNA elements, such as promoters, and promotes polymerase recycling (Rosonina et al., 
2006). 
 
2.1.1. RNA polymerases 
The ribonucleic acid polymerase (RNAP) is one of the most essential enzymes for 
life because it is implicated in the polymerization of ribonucleotides chains, the basic 
building blocks of DNA and RNA. Eukaryotes have 3 types of RNAP, each of which 
responsible for the synthesis of specific subsets of RNA. In yeast, RNA polymerase I 
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(RNAPI) and III (RNAPIII) transcribe ribosomal RNAs (rRNAs), which represents 80% of 
the total RNAs. A single unit of rDNA contains two transcribed genes, the 35S rRNA gene 
which is transcribed by RNAPI and will mature into the 5.8S, 18S and 25S (Russell and 
Zomerdijk, 2005), and the 5S rRNA gene transcribed by RNAPIII as well as transfer RNAs 
(tRNAs) and few small non-coding RNAs (ncRNAs) (Dieci et al., 2013, 2007). 
 
Even though its contribution in terms of RNA abundance is smaller, the 
transcriptional activity of the RNA polymerase II (RNAPII) is the widest and the most 
extensively studied. It synthesizes messenger RNAs (mRNA) that are translated into 
proteins. RNAPII also transcribes a variety of ncRNAs, that are  not translated because of 
their importance in gene regulation. 
2.1.2. RNAPII Rbp1 subunit and its role in the transcription elongation rate 
The RNAPII is a multiprotein complex composed of 12 subunits (Rpb1 to Rpb12), 
10 of them forming the core of the enzyme to which a subcomplex Rpb4/7 is fixed (Cramer 
et al., 2008). The largest subunit of this complex is Rpb1 (194.16 kilodaltons (kDa)) encoded 
in S. pombe by the rpb1 gene. It is the catalytic component of the enzyme and physically 
represents the bottom clamp that moves to grab the incoming DNA template and move 
forward during the transcription elongation step. 
Another component of Rpb1 is a highly conserved subdomain known as the trigger 
loop (TL), critical for rapid catalysis and selection of correct substrates (Wang et al., 2006). 
During elongation, the translocation state of the RNAPII determines whether this active site 
is available for incorporation of the next nucleoside triphosphate (NTP) into the nascent RNA 
(Kaplan, 2013). This active site of Rpb1 undergoes conformational changes to preferential 
catalysis substrate interactions to correctly matched substrates over mismatched substrates 
(Kaplan et al., 2008). One of the steps that ensure faithful addition of correct substrates is the 
interaction between residue N494 (N479 in S. cerevisiae (Wang et al., 2006)) and 2′ and 3′ 
hydroxyl groups on the NTP ribose. The assumption made so far is that NTP interactions 
with N479 (Figure 1A, black circle), very close to the RNA-DNA hybrids, may stabilize or 
begin to promote TL-folding which could explain why a N479S mutant shows an in vitro 
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elongation rate ten times slower than a wild-type (Figure 1B, Kaplan et al., 2012). Finally, 
during the same year in S. cerevisiae, Francisco Malagon has demonstrated that another 
residue in the trigger loop plays an important role for the transcription elongation rate in 
vitro. Indeed, he showed in his paper that N488D mutation causes a change in the intrinsic 
elongation properties of the enzyme, resulting in an RNAPII that is slower than the wild-type 
polymerase (Malagon et al., 2006). 
 
Figure 1. RNAPII N479 TL substitution mutants show a slower elongation rate in vitro. 
Adapted from (Kaplan et al., 2012). 
A. Diagram of ‘‘closed’’ RNAPII TL in Rpb1 in relation to nucleic acids. The black circle shows the 
mutated residue that induces a slow transcription elongation rate in vitro. 
B. RNAPII TL single substitution elongation rates as determined in vitro using reconstituted RNAPII 
elongation complexes with synthetic oligonucleotides and an RNA primer.  
2.1.3. RNA 3’ end processing and transcription termination 
In order for a gene to be correctly expressed, the transcription step must be terminated 
effectively and release the newly synthesized RNA (Proudfoot, 2016). Polyadenylation 
signals (PAS or p(A)) at the 3’ end of the genes, typically a variation of the AAUAAA 
hexamer, and a uridine-rich downstream element, are the signals required for the assembly 
A B 
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of the pre-RNA 3’ processing complex (Shi and Manley, 2015). In response to those 
elements, the cleavage and polyadenylation specificity factor and the cleavage stimulatory 
factor co-transcriptionally trigger an endonucleolytic cleavage of the pre-RNA, generating a 
free hydroxyl group at the 3′end to which adenosine monophosphate are successively added 
by poly(A) polymerases in order to protect the pre-RNA from degradation by 3’-5’ 
exonucleases (Casañal et al., 2017). However, this association makes RNAPII pausing 
(Gromak et al., 2006) which correlates with maximal recruitment of cleavage and 
polyadenylation factors (Glover-Cutter et al., 2008). 
Nevertheless, the RNAPII is still transcribing the unit. To fully complete the 
transcription termination, according to the kinetic model (also known as “torpedo” model), 
this new transcript will be a substrate of Dhp1, a processive 5'-3' exoribonuclease that catches 
up with the RNAPII and disassembles the transcription elongation complex, allowing the 
polymerase to be released and recycled for another transcription cycle (Baejen et al., 2017). 
 
Moreover, it was reported that a gene can give rise to transcripts with multiple PASs 
and that differential usage of these sites can lead to the formation of distinct mRNA isoforms, 
a phenomenon termed as alternative polyadenylation (APA) (Barabino and Keller, 1999; 
Edwalds-Gilbert et al., 1997). More recent analyses using high-throughput sequencing have 
shown that APA is very common and occurs most frequently in the 3′ untranslated region (3′ 
UTR) of mRNAs, as expected from a transcription termination feature. Even though the 
expression levels of the growing number of APA-regulatory factors can alter PAS choice in 
different ways, the mechanism underlying this is still unknown. 
2.1.4. Carboxy-Terminal Domain (CTD) of RNAPII 
While all three RNAP possess Rpb1 subunits, RNAPII distinguishes itself by a 
flexible carboxy-terminal domain (CTD) from Rpb1 subunit near the newly synthesized 
RNA, which plays a central role in transcription regulation. The CTD domain is found among 
a very large scope of organisms (Buratowski, 2009). It is comprised of tandemly repetitive 
heptapeptides with the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 
(Y1S2P3T4S5P6S7) which can vary from 26 repetitions in S. cerevisiae (Allison et al., 1985) 
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to 29 repetitions in S. pombe (Azuma et al., 1991) and 52 repetitions in mammals (Corden et 
al., 1985), underlying the scaling of CTD length with developmental complexity (Yang and 
Stiller, 2014).  
In budding yeast, cells are viable with a CTD as short as 13 heptad repeats but further 
deletion down to ten repeats is lethal, indicating that the heptad repeats are partially redundant 
for the essential role of the CTD (Nonet et al., 1987). 
In addition, work in Drosophila melanogaster showed that a truncated CTD 
composed exclusively of consensus repeats (YSPTSPS) supports Drosophila viability, but 
that a CTD with enough YSPTSPS repeats to match the length of the wildtype Drosophila 
CTD is defective (Lu et al., 2019). 
 
Altogether, these studies suggest that sequence complexity and length of the CTD are 
important in development and viability, highlighting the essential role of the CTD domain, 
but it does not seem to be required for RNAPII transcription per se. Instead, it appears that 
the CTD operates as a recruitment platform for multiple factors involved in all steps of the 
transcription process. The specificity of the recruitment of those factors depends on different 
configurations adopted by the CTD due to the combination of post-translational 
modifications and conformational changes within the CTD defined as the “CTD code” 
(Buratowski, 2003). 
2.1.5. Post-translational modification (PTM) of RNAPII CTD during 
transcription and its consequences 
CTD is potentially modified on each of the seven residues of the consensus heptads. 
Five of them can be phosphorylated (Y1, S2, T4, S5 and S7) whereas the two prolines (P3 and 
P6) can be subject to isomerization in either a cis or trans conformation (Heidemann et al., 
2013). Other PTM include S2, S5 and T4 glycosylation (Lu et al., 2016) and methylation, 
acetylation and ubiquitination of arginine residues in the non-consensus repeats (Schröder et 
al., 2013; Voss et al., 2015). 
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Nevertheless, the “CTD code” appears less complex than expected. Mass 
spectrometry shows that the phosphorylation of the serines in second (Ser2-P) and fifth (Ser5-
P) position were 100 times more abundant than other PTM. While the absolute abundance of 
a modification is not a measure of its biological relevance, we will, for the sake of brevity, 
mainly focus on the role of the major modification Ser2-P, which became the most studied 
phosphorylation in correlation with the presence of a transcription termination site. 
 
2.1.5.1. The chromatin immunoprecipitation assay: a powerful and 
versatile technique for protein-DNA interactions 
The chromatin immunoprecipitation (ChIP) is a technique that determines whether a 
protein of interest interacts directly or indirectly with DNA sequences. It provides 
information about the association of a protein of interest like a transcription factor or the 
abundance of a PTM like the Ser2-P of the RNAPII CTD. The overall process is represented 
with the Figure 2 bellow. 
First, the usage of formaldehyde allows covalent bonds in vivo between protein and 
DNA as well as between protein and protein (Wells and Farnham, 2002). Indeed, many 
protein–DNA interactions are transient, and involve multi-protein complexes to orchestrate 
biological function. 
Then, the chromatin is extracted using chemical and/or mechanical lysis and 
fragmented through either sonication (shear) or enzymatic digestion in order to have smaller 
and workable pieces of DNA (Bortz and Wamhoff, 2011). The chromatin fragments usually 
range between 300 and 500 bp.  
Afterwards, the protein of interest is immunoprecipitated using a specific antibody 
against the protein (or against a PTM). This step selectively enriches for the protein–DNA 
complex of interest and eliminates all other unrelated cellular material. 
Finally, the DNA is purified and reverse crosslinked to further be analyzed by either 
quantitative polymerase chain reaction (ChIP-qPCR) for a specific locus (Carey et al., 2009) 
or high throughput sequencing (ChIP-seq) for a genome-wide study (Robertson et al., 2007; 
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Schmidt et al., 2009). In a word, the amplified DNA will represent indirectly the abundance 
of the target along the DNA template. 
 
However, because DNA fragmentation by sonication is not a truly random process 
(Grokhovsky, 2006; Grokhovsky et al., 2011), one must include a control called input. An 
input DNA sample must be generated for each strain included in the experiment and 
undergoes the cross-linking and sonication steps but not the immunoprecipitation. The main 
purpose in the end is to normalize the signal from the ChIP experiment by the appropriate 
input for each strain. 
 
 
Figure 2. Chromatin immunoprecipitation overview. 
Proteins associated with the chromatin in living cells or tissues are covalently bonded using 
formaldehyde, the DNA–protein complexes are then sheared into ∼300-500 bp DNA fragments using 
either enzymatic digestion or physical shearing by sonication. Cross-linked DNA fragments 
associated with the protein(s) of interest are selectively immunoprecipitated from the cell debris using 
specific antibody coupled here to magnetic beads. After the crosslinks are reversed, the DNA 
fragments are purified, and their sequence is determined. These DNA sequences are reflecting the 
position and abundancy of the protein of interest in vivo. The DNA undergoes PCR amplification 
using primers targeting any genomic locus of interest. These DNA sequences can be subjected to 
several downstream analysis techniques. 
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2.1.5.2. Pattern of phosphorylated CTD Ser2 across transcription units 
ChIP experiments using antibodies specific to Ser2-P revealed that this modification 
has a specific spatio-temporal framework in correlation with transcription cycle. 
In fission yeast, Ser2 is phosphorylated during transcriptional elongation by its major 
kinase Lsk1 (Coudreuse et al., 2010). Previous ChIP-seq experiments in fission yeast from 
Bachand’s lab (Larochelle et al., 2018) revealed a CTD phosphorylation pattern across 
transcription units where Ser2-P steadily increased along the gene body during transcription 
elongation and sharply peaked to its maximum level toward the 3’ end of the coding genes 
(Figure 3A) as well as the non-coding genes (Figure 3B, in this example snoRNAs are used 
as a representation of non-coding gene transcription termination), downstream of the 
polyadenylation site (p(A)). It is then removed by the Fcp1 phosphatase (Cho et al., 2001).  
 
 
  
Figure 3. Genome-wide occupancy of the RNAPII and CTD modification in fission 
yeast. 
Adapted from (Larochelle et al., 2018). 
Average ChIP-seq profile of total RNAPII (Rpb1) and the indicated CTD modifications in a wildtype 
(WT) strain across 4755 mRNAs (A) and 24 monocistronic snoRNAs (B) with a mapped poly(A) site 
in minimal medium. 
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2.1.5.3. Coordination between Ser2-P and transcription termination 
Several subunits of the 3’ processing complex, such as Rna14, Pcf11 or Seb1, show 
a genome-wide binding profile at the 3’ end of the coding genes (Figure 4A) as well as the 
non-coding genes (Figure 4B, in this example snoRNAs are used as a representation of non-
coding gene transcription termination) (Larochelle et al., 2018). Therefore, an easy 
correlation has been made between the genome-wide profiles of Ser2P and 3’ processing 
factors which both peak right after the poly(A) site. Indeed, many of those factors directly 
interact with the CTD of RNAPII via their conserved CTD-interacting domain (CID), 
including Pcf11 and Seb1, which preferentially interact with Ser2P (Lunde et al., 2010; 
Wittmann et al., 2017).  
 
 
 
Figure 4. S. pombe mRNA 3′ end processing and transcription termination factors are 
recruited at the 3′ end of coding and non-coding genes. 
Adapted from (Larochelle et al., 2018). 
Average ChIP-seq profile of the indicated mRNA 3′ end processing factors modifications in a WT 
strain across 4755 mRNAs (A) and 24 monocistronic snoRNAs (B) with a mapped poly(A) site in 
minimal medium. 
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2.1.6. An example of gene regulation via non-coding RNA 
Phosphate homeostasis in S. pombe is achieved by the regulation of the transcription 
of genes encoding three proteins involved in extracellular phosphate mobilization: a cell 
surface acid phosphatase Pho1, an inorganic phosphate transporter Pho84, and a 
glycerophosphate transporter Tgp1, with all three genes dependent on transcription factor 
Pho7 binding at their promoters (Carter-O’Connell et al., 2012). These genes are repressed 
during growth in phosphate-rich medium and induced during phosphate starvation. 
Recent studies have unveiled a role for long non-coding RNAs (lncRNAs) in 
phosphate-regulated expression of the pho1 and tgp1 genes. In the case of tgp1, the lncRNA 
nc-tgp1, initiating 1865 nucleotides (nt) upstream of the tgp1 AUG start codon, represses 
tgp1 in cis during phosphate-replete growth. Indeed, tgp1 is de-repressed when the nc-tgp1 
locus is disrupted by deleting the nc-tgp1 transcription start site (Ard et al., 2014). Moreover, 
the transcription factor Pho7 binds 187 nt upstream of the tgp1 start codon (Schwer et al., 
2017) exactly where the polyadenylation signal of nc-tgp1 is (Figure 5, PAS2). The 
assumption made so far is that transcription of the upstream nc-tgp1 lncRNA in cis interferes 
with expression of the downstream gene tgp1 in phosphate-replete cells, likely by displacing 
the Pho7 transcription factor from tgp1 promoter because of transcription termination of nc-
tgp1. 
 It has been shown more recently that the same long non-coding RNA has another 
PAS (Figure 5, PAS1) more upstream from PAS2, leading to the discovery of a shorter RNA 
derived from nc-tgp1 locus (Sanchez et al., 2018). Mutating PAS1 abolishes de-repression 
of the tgp1 downstream, but how alternative polyadenylation of nc-tgp1 regulates tgp1 
expression is still unknown. 
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Figure 5. Schematic representation of nc-tgp1 and tgp1 loci. 
The tandem nc-tgp1–tgp1 locus is shown with the nc-tgp1 and tgp1 transcription start site indicated 
by the black arrows and the tgp1 ORF depicted as a white bar with arrowhead indicating the direction 
of transcription. The nc-tgp1 transcript has a two polyadenylation sites, a proximal one (PAS1) from 
504 nucleotides to the transcription start site and a distal one (PAS2) from 1636 nucleotides to the 
same transcription start site. The transcription factor Pho7 binds the chromatin upstream of tgp1 
promoter. The tgp1 transcript has a polyadenylation site (PAS3) from 2101 nucleotides to its 
transcription start site. 
2.1.7. Transcriptome analysis by RNA-sequencing (RNA-seq) 
Quantification of RNA transcripts is a critical step to understand the mechanism of 
gene regulation. The recent development of RNA amplification coupled to next generation 
sequencing revolutionized transcriptome analysis by providing the tools necessary to study 
the total cellular content of RNA using RNA-seq pipelines (Figure 6). Different library 
preparation protocols are available allowing the focus on different classes of RNA through 
different enrichment steps. Such strategies include polyA enrichment, rRNA depletion (or 
ribo-depletion) and small RNA enrichment (Conesa et al., 2016; Hrdlickova et al., 2017; 
O’Neil et al., 2013). Then RNAs are fragmented and reverse transcribed into complementary 
DNAs with appropriate ligated adapters for sequencing because DNA is more stable and 
suitable for amplification (use of DNA polymerase). 
 Furthermore, the sequencer produces millions of raw reads that need to be trimmed 
in order to remove the adapters sequences as well as some low quality bases associated with 
a low Phred score (Ewing et al., 1998). The remaining good quality reads are aligned to a 
reference genome (if available) using alignment tools that consider splicing events, otherwise 
reads overlapping exon-exon junctions could not be aligned. 
 Finally, the aligned reads are quantified for each gene and, at least, normalized by 
sequencing depth. If different strains or conditions are used in the experiment, differential 
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gene expression analyses are typically carried out to assess the genes that are significantly 
differently expressed. 
 
 
Figure 6. Overview of a typical RNA-Seq experimental workflow. 
 
3. Problem statement, objectives and assumptions 
Throughout the progression of transcription elongation, the RNAPII recruits different 
proteins in order to process the pre-mRNA that is co-synthesized. It is easy to imagine that 
changes in elongation rate could influence the co-transcriptional processing of RNAs that 
occurs during the elongation step, but how the transcription elongation rate influences the 
transcriptome remains poorly understood. 
Some studies have started to answer this question and characterized mutations in 
RNAPII Rpb1 subunit in the budding yeast that slowed down the transcription elongation 
rate in vitro (Kaplan et al., 2012b; Malagon et al., 2006). Those mutations have been used in 
mammalian cells (Fong et al., 2015; Hazelbaker et al., 2013) and in the budding yeast 
(Aslanzadeh et al., 2018) to show an effect of elongation rate on different features of RNA 
maturation and gene expression. But it has never been done in fission yeast S. pombe. Here, 
we used a genome edited mutant of RNAPII that possesses a homologous mutation (N494D) 
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previously described in S. cerevisiae by Francisco Malagon in 2006 that decreases 
transcription elongation rate. 
 
In this work, we investigate the transcriptome-wide effect of a slow transcription 
elongation rate on global gene expression. The first objective is to validate that transcription 
elongation rate influences gene expression in fission yeast, and if there are some genes that 
are more affected than others. In addition, I consider genes that use alternative 
polyadenylation, especially the use of the proximal PAS compared to the distal one. Indeed, 
we can simply imagine a train going very slowly and making two or more stops (represented 
here by two or more PAS). It is most likely that passengers will stop the trip at the first stop 
instead of the second one because they are bored of this slow trip and want to get out of the 
train (represented here by transcription termination at the proximal PAS because the RNAPII 
slowing transcribes). 
Finally, if gene expression is indeed affected, then a focus will be made on the most 
significantly affected gene in order to have some mechanistic insights about how the 
transcription elongation rate influences gene expression. 
Materials and Methods 
Yeast strains and media 
A list of all S. pombe strains used in this study is provided in Supplementary Table 
1. Cells were routinely grown at 30 °C in YES media (3% glucose, 0.5% yeast extract, 
supplemented with adenine, histidine, leucine and uracil) or Edinburgh minimal media 
(EMM). Cells were collected at OD600nm of ∼0.5-0.7. Gene disruptions and C-terminal 
tagging of proteins were performed by PCR-mediated gene targeting (Bähler et al., 1998) 
using lithium acetate method for yeast transformation. Expression of tagged proteins was 
confirmed by western blotting and knockouts strains by the absence of RNA by RT-PCR. 
 
Growth assays 
For spotting assays, exponential cultures of S. pombe cells were adjusted to an 
OD600nm of 1.0, and serially diluted tenfold using water. Each dilution was spotted (3 μL per 
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spot) on YES plates with or without hydroxyurea or KCl. Plates were incubated at 30 °C for 
2–7 days. For liquid growth assays, cells were grown in either EMM or YES media and 50 
μl of appropriated early-log-phase cell suspensions (OD600nm of 0.02) were added to 50 μl of 
either EMM or YES. Samples were prepared in triplicate in Costar 96-well noncoated 
polystyrene microplates, and cell growth was monitored with a PowerWave microplate 
spectrophotometer reader (BioTek Instruments) with the following software settings: the 
optical density was measured at 660 nm, incubation was kept at 30 ± 0.1 °C, the microplates 
were subjected to continuous shaking at intensity 2, during 595 s. Readings were done every 
10 min during a 48h period. The spotting and liquid growth assay experiments was repeated 
twice. 
 
RNA preparation and analyses 
Total RNA was extracted from one WT strain and two biological replicates of the 
slow mutant using the hot-acid phenol method. For Reverse Transcription Quantitative PCR 
(RT-qPCR) RNA samples (1 µg of total RNA) were treated with Promega DNase RQ1 and 
reverse transcribed using Qiagen Omniscript RT. cDNA was diluted 100-fold and analyzed 
on a LightCycler® 96 Instrument using perfecta SYBR supermix in the presence of a 150 nM 
concentration (each) of gene-specific primers in 15 μl reaction mixtures. For the calculation 
of RNA abundancy, the threshold cycle (CT) of each average from three technical replicates 
was subtracted to the CT of the housekeeping gene nda2 (coding for tubulin alpha 1). The 
resulting difference in threshold cycles (ΔCT) was used to calculate the relative change in 
RNA levels between the WT and the mutant by calculating the 2ΔCT value. The RNA 
abundancy was graphically presented as the relative abundance in the mutant, normalized to 
nda2 and relative to the WT. 
Library preparation and Illumina sequencing 
Library preparation was performed at the Plateforme de l'Université de Sherbrooke. 
Briefly 10 µg of total RNA was used to perform a DNase treatment on a RNeasy Mini Kit 
column (Qiagen). DNase treatment on the column and RNA recovery were performed as per 
manufacturer’s protocol. RNA integrity was assessed with Agilent 2100 Bioanalyzer 
(Agilent Technologies). 
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Ribo-depleted RNA was isolated from 1.25 µg of total RNA using Illumina Ribo-
Zero (yeast), as per manufacturer's protocol, the RNA cleanup was performed by ethanol 
precipitation, and depleted RNA was resuspended in 10 µl of water. Quality and quantity 
assessments were performed on Agilent pico Chip. The RNA-seq library was then built using 
the Epicentre SSV21106 kit from 9 µl isolated ribo-depleted RNA with 13 cycles of 
amplification. Library quality was assessed using the Agilent DNA HS Chip. Library 
quantification was performed by Qubit quantification. Pooled libraries were sequenced at 
100 bp paired-end reads using Illumina HiSeq 4000 PE100 at McGill University and Génome 
Québec Innovation Centre Sequencing Service. A summary of the output from the sequencer 
is listed in the Table 1 bellow.  
 
Table 1. Statistics of the samples after the sequencing run 
Name Number of reads 
sequenced 
Number of bases 
sequenced 
Average quality 
(Phred) 
% duplicata 
WT 40 853 659 8 170 731 800 38 55.3 
Slow1 53 496 159 10 699 231 800 39 64.7 
Slow2 39 265 137 7 853 027 400 39 65.3 
 
 
RNA-seq data analysis: MUGQIC RNA-Seq pipeline 
Read processing, alignment and differential expression analysis were done using the 
MUGQIC 1.10.4 pipeline (https://bitbucket.org/mugqic). Briefly, reads were trimmed from 
the 3' end to have a Phred score of at least 30 per nucleotide. Illumina sequencing adapters 
were removed from the reads, and all reads were required to have a length of at least 32 bp. 
Trimming and clipping was performed using Trimmomatic 0.36 software (with THREADS: 
30, MINLEN: 32 and TRAILING: 30) (Bolger et al., 2014). The filtered reads were aligned 
to a reference genome. The genome used in this analysis was S. pombe assembly ASM294v2. 
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Each readset was aligned using STAR 2.5.1 with --runThreadN 46 and all other parameters 
by default (Dobin et al., 2013) which created a Binary Alignment Map file (.bam). Then, all 
readset BAM files from the same sample were merged into a single global BAM file using 
Picard 2.0.1. Raw read counts were obtained from EnsemblGenomes23 (.gtf) using HTSeq 
0.11.0 (Anders et al., 2015) with -m intersection-nonempty and all other parameters by 
default. Even though the multimappers are kept in the BAM file, HTSeq does not count them. 
The results of the differential gene expression analysis were generated using R Bioconductor 
3.1.2 with the package DESeq 1.36.0 (Anders and Huber, 2010) and default parameters. 
Screenshots of processed data at different loci were taken from the IGV-web browser 
(Robinson et al., 2011). 
 
AnGeLi: Analysis of Gene Lists 
Functional enrichment of gene lists was performed using the AnGeLi tool, which 
applies a two-tailed Fisher's exact test (Bitton et al., 2015). The inputs were the genes 
significantly (p-value < 0.05) and differentially expressed (|Log2_FC| > 0.5). No pre-defined 
background was selected (“all genes”) and the results with a p-value smaller than 0.01 were 
displayed. 
 
Protein analysis 
Total cell extracts were prepared by harvesting mid-log cells in ice-cold lysis buffer 
(50 mM Tris (pH 7.5), 5 mM MgCl2, 150 mM NaCl and 0.1 % NP-40) containing a cocktail 
of protease inhibitors (1x PMSF and 1x PLAAC) with half of a phosphor STOP tablet, prior 
to lysis with glass beads using a FastPrep instrument (MP Biomedicals). Clarified lysates 
were normalized for total protein concentration using the Bradford protein assay. 30 µg of 
proteins were separated by SDS–PAGE, transferred to nitrocellulose membranes, and 
analyzed by immunoblotting using either, a mouse monoclonal antibody specific to α-tubulin 
(Sigma-Aldrich, T5168; 1:1,000 (v/v) dilution), or a rabbit polyclonal antibody against 
protein A (Sigma-Aldrich, P3775; 1:10,000 (v/v) dilution) in the case of HTP-tagged Seb1 
or TAP-tagged proteins. Membranes were then probed with goat anti-rabbit or anti-mouse 
secondary antibodies conjugated to IRDye 800CW (LI-COR, 926-32213; 1:15,000 (v/v) 
  
19 
19 
dilution) and AlexaFluor 680 (Life Technologies, A21057; 1:15,000 (v/v) dilution), 
respectively. Detection of the proteins was performed using an Odyssey infrared imaging 
system (LI-COR). 
Chromatin immunoprecipitation (ChIP) assays  
For each IP, 50 mL of cells were grown at OD600nm of ∼0.5-0.7 at 30 °C in EMM. 
Formaldehyde was added to a final concentration of 1% with diluent solution (0.143 M NaCl, 
1.43 mM EDTA and 71.34 mM HEPES-KOH pH 7.5), cells were incubated at room 
temperature (RT) for 20 min and manually agitated every 5 min. After quenching the reaction 
with glycine (final concentration of 360 mM) for 5 min at RT, cells were washed twice with 
cold Tris-buffered saline (20 mM Tris–HCl pH 7.5, 150 mM NaCl). Cell pellets from 50 ml 
cultures were resuspended in 500 μL of lysis buffer (50 mM HEPES-KOH pH 7.5, 140 mM 
NaCl, 1 mM EDTA pH 8.0, 1% Triton X-100, 0,1% Na-deoxycholate) containing protease 
inhibitors (1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, 10 μg of aprotinin/μL, 
1 μg of leupeptin/μL, and 1 μg of pepstatin/μL) and disrupted vigorously with glass beads 
three times for 30 s using a FastPrep instrument. Samples were then sonicated 10 times for 
10 s at 20% using a Branson digital sonifier. Whole-cell extracts (WCE, 500 μL) were 
incubated with a mix of 30 µL of beads coupled to 2 µg of antibodies. The magnetic beads 
coupled to the antibodies of interest used in this study are listed in the Table 2 below.  
 
Table 2. List of antibodies and beads used in this study for ChIP analyses. 
Target Antibody Beads 
RNAPII Rpb1 non-phosphorylated CTD 
(total RNAPII) 
8WG16 (ENZ-ABS132A-0100) 
Dynabeads Pan Mouse IgG #110.41 
(Invitrogen) 
RNAPII Rpb1 phosphorylated CTD Ser2 Clone 3E10 (04-1571) Dynabeads Protein G #10003D (Invitrogen) 
RNAPII Rpb1 phosphorylated CTD Ser5 Clone 3E8 (04-1572) Dynabeads Protein G #10003D (Invitrogen) 
RNAPII Rpb1 phosphorylated CTD Ser7 Clone 4E12 (04-1570) Dynabeads Protein G #10003D (Invitrogen) 
TAP/HTP tag  
Dynabeads Pan Mouse IgG #110.41 
(Invitrogen) 
 
Beads were washed twice with 1 mL of lysis buffer, twice with 1 mL of lysis buffer 
plus 500 mM NaCl, twice with 1 mL of wash buffer (10 mM Tris-HCl pH 8.0, 250 mM LiCl, 
0.5% NP-40, 0.5% sodium deoxycholate, and 1 mM EDTA) and once with 1 ml of Tris-
EDTA (TE; 10 mM Tris-HCl pH 8.0, 1 mM EDTA). Bound material was eluted by 
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resuspending beads in 50 μL of elution buffer (50 mM Tris-HCl pH 8.0, 10 mM EDTA, and 
1% SDS) and incubated in a Thermomixer Eppendorf for 15 min at 65 °C at 1200 rpm with 
additional slow vortex every 5 min. Samples were centrifuged briefly and the cross-linking 
was reversed by incubating 50 μL of supernatant with 120 μL of TE plus 1% SDS or 5 μL of 
WCE with 95 μL of TE plus 1% SDS during overnight at 65 °C. Samples were treated with 
proteinase K, extracted twice with phenol chloroform isoamyl alcohol pH 8.0 (Invitrogen), 
extracted once with chloroform (Bioshop), precipitated with ethanol, and resuspended in 30 
μL of TE. DNA was then treated with 10 µg of RNase A at 37 °C for 60 min and purified 
using a PCR purification kit from Qiagen. DNA from the inputs were diluted 100-fold and 
DNA from the IPs were diluted 20-fold and analyzed on a LightCycler® 96 Instrument using 
perfecta SYBR supermix in the presence of a 150 nM concentration (each) of gene-specific 
primers in 15 μL reaction mixtures. Protein density was calculated by subtracting the CT of 
each average from three technical replicates of the IP from the CT of the average from three 
technical replicates of the input. The resulting difference in threshold cycles was used to 
calculate the relative abundance of the immunoprecipitated target by calculating the 2ΔCT 
value. The protein binding abundancy in the mutant was graphically represented normalized 
to the input and relative to the WT. Some targets, like the phosphorylated CTD or 3’end 
processing factors, needed to be normalized to total RNAPII because they were dependent 
of the abundancy of RNAPII at a given locus. 
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Results 
1. Genome-wide consequences of a slow transcription elongation rate 
To gain further insight into the coupling between transcription elongation rate and 
gene expression, we examined the genome-wide gene expression profile between a wild-type 
(WT) strain and two biological replicates containing the same slow rpb1 allele 
(Supplementary Table 1). A total average of 44,538,318 reads were obtained from paired-
end next generation RNA sequencing (RNA-seq) on total ribo-depleted RNA. On average, 
only 8,328 reads did not meet the quality requirements (Phred score per nucleotide > 30 amd 
minimum length of 32 nucleotides) and were removed from the analysis. After aligning the 
good quality reads (with an average read length of 197 nt) to the S. pombe ASM294v2 
reference genome, we obtained, on average, 39,768,507 uniquely mapped split reads, 4.79% 
reads mapped to less or equal than 10 loci, 0.42% reads mapped to more than 10 loci and 
5.27% reads unmapped (too short). 
1.1. Slow rpb1 allele significantly affects gene expression 
As a classic purpose of an RNA-seq experiment, we wanted to know how many genes 
were up or down-regulated in the slow mutants compared to the WT. To investigate this, raw 
reads were quantified for 7,005 genes by HTSeq-count using EnsemblGenomes23.gtf file, 
producing a number of reads for each gene in Counts Per Million (CPM) normalized to the 
size of the library. Since here we iteratively compare each gene expression between different 
strains, there is no need to normalize to the size of the gene because it will be the expression 
of the same gene studied in the WT and the slow mutants. 
Raw read counts generated by HTSeq were used as input for the differential gene 
expression analysis with DESeq. To do so, 6,633 filtered genes (CPM > 3) were statistically 
compared between the WT and two biological replicates of the slow mutant (Figure 7A). 
The difference in expression level in the slow mutant compared to the WT was significantly 
(adjusted p-value<0.05) greater than 0.5-fold for 382 genes (Supplemental Table 2) and 
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significantly lower than 0.5-fold for 494 genes (Supplemental Table 3). As a side note, tgp1 
appears to be the most significant up-regulated gene in the slow mutant (Figure 7A). 
 
Unfortunately, this result alone does not allow us to conclude anything besides how 
many genes are up and down-regulated in the context of a slow rpb1 allele. However, such 
gene lists often contain valuable, hidden biological information which can be uncovered by 
submitting those lists to AnGeLi (Analysis of Gene Lists), an online tool specifically 
designed for the fission yeast (Bitton et al., 2015). It takes as an input a list of systematic 
gene identifiers, and searches for any enrichment of common features using different sources 
such as specific GO categories, phenotypes, or published gene lists. Consequently, the up-
regulated genes in the slow mutant present significantly enriched categories related to 
different stress responses (Figure 7B), which correlates with the slow growth observed in 
minimal media (Supplemental Figure 1), and the increased sensitivity to DNA damage and 
osmotic stress (Supplemental Figure 2). Furthermore, the down-regulated genes in the slow 
mutant present some significantly enriched categories related to ribosomal RNAs, which can 
be explained by the state of stress of the slow mutants. But, interestingly,  some categories 
related to the non-coding RNAs were also identified (Figure 7C). In other words, there is an 
enrichment of down-regulated ncRNAs as well as genes involved in their processing. 
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Figure 7. Transcriptome-wide analysis of gene expression changes in S. pombe Rpb1 
slow mutant. 
(A) Volcano plot showing differentially expressed genes between the Rpb1 slow mutant and the WT. 
The x-axis is log2 ratio of gene expression levels between the WT and the slow mutant; the y-axis is 
adjusted p-value based on -log10. Data for genes that were not classified as differentially expressed 
are plotted in black. The red dots represent the differentially expressed genes in the slow mutant 
compared to the WT based on p-value.adj<0.05 and an absolute log2 fold change greater than 0.5. 
Only the top hits of the significantly differentially expressed genes are labelled (p-value.adj<5E-10) 
(complete list in supplementary tables). SPBC660.05 has an arrow because the p-value is highly 
significant. (B)-(C) Enrichment analysis of functional categories of respectively 382 genes 
significantly up-regulated and 494 genes significantly down-regulated using AnGeli (FDR<0.01). 
The percentage represents the frequency of genes significantly up or down-regulated in each category. 
Only significant enrichments at a corrected p-value<1.3E-06 are plotted (complete results in 
supplementary tables). A total of 208 genes belong to at least two different enriched categories. The 
colored arrow represents the intensity of the significance for the enriched categories, the darker it is 
the more significant the category is enriched. 
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1.2. Proximal cleavage sites are preferentially used in the rpb1 slow mutant 
In S. cerevisiae, mutating the transcription termination factor Sen1 in a strain already 
containing the same slow rpb1 allele produced shorter non-coding transcripts and lead to a 
model where the termination window is narrow with earlier termination events (Hazelbaker 
et al., 2013). This same model can be expected in the context of alternative polyadenylation 
(APA), where the slow mutant would favor transcription termination at the proximal 
polyadenylation signal (PAS) instead of the distal one. 
To verify this assumption, our RNA-seq data was merged with published sequencing 
data of the 3′ end of RNA poly(A) (Liu et al., 2017). The purpose here was, first, to annotate 
genomic segments strand specific reflecting the usage of multiple PAS for gene expression. 
To consider a valid APA for our study, we set up a threshold of 50 nucleotides between two 
signals of APA in the 3’UTR of every annotated gene (coding and non-coding). We ended 
up with 1723 genes presenting at least two different poly(A) sites in their respective 3’UTR 
(1538 mRNA, 183 lncRNA, 2snRNA). Secondly, RNA-seq reads counts were performed on 
each segment allowing us to compare the proportional expression of the segments within the 
same gene between the WT and the slow mutant to find RNA-seq expression patterns 
consistent with differential APA usage. Typically, the first segment represents reads from 
transcription start site (TSS) to the proximal PAS (first PAS), and the second segment 
represents reads from the proximal PAS to distal PAS (second and more PAS). A ratio for 
each gene was calculated between the first segment relative to the second one 
(
𝑝𝑟𝑜𝑥𝑖𝑚𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡
𝑑𝑖𝑠𝑡𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡
) to finally compare those ratios in the slow mutant relative to the WT and 
(
𝑝𝑟𝑜𝑥𝑖𝑚𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑊𝑇
𝑑𝑖𝑠𝑡𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑊𝑇
𝑝𝑟𝑜𝑥𝑖𝑚𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑠𝑙𝑜𝑤
𝑑𝑖𝑠𝑡𝑎𝑙 𝑠𝑒𝑔𝑚𝑒𝑛𝑡 𝑠𝑙𝑜𝑤
) and plot this in a volcano plot (Figure 8A). For this analysis, ratios have 
not been normalized to the length of the segments because here the same segment is studied 
in two different conditions (WT vs slow) so it reflects the same situation when expression of 
a gene is studied in two different conditions, one can keep the CPM unit (normalization for 
sequencing depth) and does not have to normalize for gene length. This resulted in 441 genes 
in the two biological replicates slow mutants with ratios at least twice smaller (FDR < 0.05; 
Log2 FC < -1) than the WT ratio, indicating that proximal PAS is privileged for those 441 
genes in the slow mutant. The "ratio of ratios" is an estimate of the change in the proportional 
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usage of the proximal PAS over the distal PAS. A negative Log2 of "ratio of ratios" is 
indicative that the RNA-seq data is consistent with premature termination as we observe a 
proportional decrease in RNA-seq coverage after the proximal PAS in the slow mutant. 
Surprisingly, 75 genes in the slow mutant have their ratio at least twice greater than the WT 
ratio (FDR < 0.05; Log2 FC > 1), indicating that distal PAS is privileged for those 75 genes 
in the slow mutant, but will not be further investigated in this work. 
Since it appears that proximal PAS are more used than distal ones in the slow mutant 
genome-wide, we next asked if it was also the case for the non-coding RNA upstream of tgp1 
(nc-tgp1). By focusing on the nc-tgp1 locus, we first confirmed the presence of the previously 
described PAS1 and PAS2 as well as a PAS1 “bis”, very close to the PAS1 but still twice 
less used than the PAS1 (Figure 8B). Then after combining the RNA-seq data, we found that 
the PAS1 is preferentially chosen in the slow mutants because the reads within the segment 
between PAS1 bis and PAS2 are relatively twice less abundant than the segment 1 (from TSS 
to PAS1) in the slow mutants comparatively to the WT. 
 
 
Figure 8. Proximal cleavage sites are preferentially used in the Rpb1 slow mutant. 
(A) Volcano plot showing differentially PAS usage between the WT and the two biological replicates 
slow mutants. The blue dots represent genes whose APA is significantly affected (FDR < 0.05) by a 
slow transcription elongation rate either favoring the proximal PAS (Log2 FC < -1) or distal PAS 
(Log2 FC > 1). The segment ratio is made from RNA-seq reads mapping at a first segment from the 
TSS to the first PAS and a second segment from the first PAS to the last one. The ratios are then 
compared between the WT and the two biological replicates of the slow mutant to differentially 
analyze proximal or distal PAS usage. (B) Graphical representation of merged data between RNA-
seq and published 3'Ends of polyA+ RNA sequencing at nc-tgp1 locus. The vertical blue lines 
represent the frequency of PAS usage related to the left y-axis. The different PAS are annotated with 
blue arrows along nc-tgp1 gene x-axis. The two horizontal red lines represent the RNA-seq reads 
from the two biological replicates slow mutants. Three segments are calculated, the first one from the 
TSS to the PAS1, a second one from PAS1 to PAS1 bis and a third one from PAS1 bis to PAS2. All 
three segments are calculated relatively to the first segment and then differentially analyzed between 
the WT and slow mutants. 
A B 
  
26 
26 
2. Slowdown of transcription elongation rate up-regulates tgp1 by down-regulating an 
upstream ncRNA 
Genome-wide analyses have revealed that a slow transcription elongation rate gives 
rise to different up and down-regulated genes relatively to a WT strain, as well as a tendency 
to process transcription termination at a more proximal polyadenylation signal. In fact, it 
appears that tgp1 is significantly affected in both of those analyses in the slow mutants. 
Indeed, on one hand, it is the most significant up-regulated gene, and on the other hand, 
alternative polyadenylation seems to occur more often at the proximal PAS (PAS1). 
In order to visualize the output of the differential gene expression analysis, a 
screenshot of the read coverage at the genomic region of tgp1 was taken to focus on the 
overexpression of tgp1 in the slow mutants (Figure 9A, red), which actually overshadows 
completely the read coverage of the WT when both profiles are stacked. Astonishingly, it 
seems to be the contrary at nc-tgp1 locus where the read coverage of the WT (Figure 9A, 
blue) is superior compare to the slow mutants. 
This observation has been confirmed by reverse transcription followed by polymerase 
chain reaction (RT-qPCR) using 5 PCR targets in nc-tgp1 and 3 PCR targets in tgp1 ORF. 
There is a 6-fold overexpression of tgp1 (amplicons 6 to 8) and underexpression of nc-tgp1 
(amplicons 1 to 5) in the slow mutant relative to the WT (Figure 9B). From this, one must 
take into account the overexpression of tgp1 previously computed through the differential 
gene expression analysis (Figure 7A), and the down-regulation of the non-coding RNA nc-
tgp1 included in the enriched category of “nc-RNA levels” from the list of genes down-
regulated (Figure 7C). 
 
Since it is known that a deletion of nc-tgp1 de-represses tgp1, we can infer that 
overexpression of tgp1 seen in the slow mutant is due to the underexpression of nc-tgp1 (Ard 
et al., 2014). Then, this underexpression of nc-tgp1 could be a consequence of the greater 
use of the PAS1 in the slow mutant, previously computed (Figure 8B), although this still 
needs to be proven from a molecular point of view. 
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Figure 9. Imbalance of expression at nc-tgp1 and tgp1 loci between the WT and the slow 
mutants. 
(A) Screenshot of RNA-seq read coverage from IGV browser at nc-tgp1 and tgp1 loci with PAS usage 
from 3'Ends of polyA+ RNA sequencing published data. Black oriented rectangles represent the 
different annotated ORFs. The mapped reads are represented either in blue for the WT or red for the 
two biological replicates slow mutants. The PAS usage is represented by black vertical lines and are 
annotated by blue arrows for nc-tgp1 locus. (B) RT-qPCR analysis of tgp1 and nc-tgp1 expression in 
the slow mutant relative to the WT after normalization to nda2 (tubulin alpha 1). Error bars represent 
standard error for 3 independent experiments. 
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3. The proximal PAS of nc-tgp1 is preferentially used in the slow mutant 
In order to gather mechanistic evidence that a slow transcription elongation rate 
favors early termination in the nc-tgp1 locus, different ChIP assays have been carried out 
using 8 PCR targets at nc-tgp1 and tgp1 loci (Figure 10A).  
First, we looked at how RNAPII density is allocated at those genes with the 
hypothesis that if there is early termination of transcription, then we would see a quicker 
decrease of RNAPII density in the 3’end of nc-tgp1 in the slow mutant.  
 
In the WT strain, maximum RNAPII is reached around PAS1 and then decreases to 
the basal level for transcription of tgp1 (Figure 10B, black bars). Interestingly, the slow 
mutant follows the same pattern with an augmentation around PAS1 but 3 times lower than 
the WT. In addition, RNAPII density in the slow mutant is 3 times higher in tgp1 ORF 
(Figure 10C), which correlates with its previously validated overexpression (Figure 
9).These results show that, on one hand, RNAPII density decreases faster in the slow mutant 
compare to the WT when approaching PAS1, and on the other hand, RNAPII density 
increases in the slow mutant compared to the WT when tgp1 is transcribed. 
According to what is known about tgp1 regulation, if transcription termination occurs 
more frequently at PAS1, then there would be less transcription interference around the tgp1 
promoter. In that case, it could lead to more binding ability for the transcription factor Pho7. 
Indeed, as expected, after purifying Pho7-TAP and amplifying the regions around tgp1 
promoter, a significant 3-fold enrichment (p-value < 0.01) was observed in the slow mutant 
compare to the WT at the genomic region where Pho7 is known to bind (Figure 10D), with 
similar expression of tagged protein (Figure 10E). 
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Figure 10. rpb1 slow allele shows altered RNAP2 density at the tgp1 locus that allow 
increase Pho7 recruitment. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The Pho7 binding site in the tgp1 promoter is 
highlighted by an orange hexagon. The eight PCR amplicons are represented by black horizonal 
segments numbered from 1 to 8. (B)-(C) Rpb1 ChIP analysis across nc-tgp1 and tgp1 loci in WT 
(black) vs slow mutant (grey), error bars represent standard error for 10 independent experiments. 
(D) ChIP analysis of Pho7 binding at the tgp1 promoter in WT (black) vs slow mutant (grey), error 
bars represent standard error for 3 independent experiments. Student’s t-test *p-value < 0.01. (E) 
Western blot analysis of chromosomally-tagged Pho7-TAP in WT and slow mutant expressing cells. 
A WT no tagged Pho7 was used as a negative control. Tubulin was used as a loading control. 
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3.1. Altered distribution of transcription termination factors between proximal 
and distal PAS of nc-tgp1 in rpb1 slow mutant 
Genome-wide analyses have shown global recruitment of mRNA 3′ end processing 
factors at the end of ncRNA genes (Larochelle et al., 2018). Considering the assumption that 
PAS1 of nc-tgp1 is preferentially used in the context of a slow transcription elongation rate 
raised the question as to what the enrichment of those transcription termination factors at the 
PAS1 in the slow mutant would be compared to the WT. To verify this, we used ChIP-qPCR 
to examine the binding profile of proteins with conserved roles in mRNA 3′end processing 
and transcription termination. This analysis included two independent components of the 
cleavage and polyadenylation factor I (CFI) complex, namely Rna14 and Pcf11, as well as 
Seb1 because this protein was shown to be important for 3′ end processing of both mRNAs 
and ncRNAs (Lemay et al., 2016). 
 
Consistent with roles in 3′ end processing at mRNA and ncRNA genes, Rna14, Pcf11 
and Seb1 all showed strong binding at the PAS1 and PAS2 (Supplemental Figure 3 and 4). 
Since those factors are recruited by RNAPII CTD, it is necessary to normalize their respective 
profile by RNAPII density. Interestingly, when ChIP assays profiles from independent 
biological replicates were analyzed in the slow mutant relative to the WT, a noticeable 
decrease of the density of those factors was discovered near the PAS2 (Figure 11B, 11C, 
11D, PCR target number 6). In contrast, an important increase of the density of those factors 
was present around the PAS1 (Figure 11B, 11C, 11D, PCR targets number 1, 2 and 3), even 
though the Pcf11 binding profile showed the least drastic reallocation between PAS2 and 
PAS1 (Figure 11C). Finally, the levels of Rna14-TAP, Pcf11-TAP and Seb1-HTP, 
expressed from their respective promoter were similar between the WT and the slow mutant 
(Figure 11E), suggesting that the results observed do not come from an overexpression of 
tagged proteins. 
 
 Based on these results, we conclude that there is an enrichment of transcription 
termination factors at PAS1 in the slow mutant relative to the WT. But more importantly, 
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due to the decrease of the density of those factors at PAS2, it suggests a redistribution of 
those factors from PAS2 toward PAS1 when a slowdown of transcription elongation occurs. 
 
 
   
 
Figure 11. Altered distribution of Rna14, Pcf11 and Seb1 at nc-tgp1 locus in slow rbp1 
allele. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The eight PCR amplicons are represented by black 
horizonal segments numbered from 1 to 8. (B-C) Average density of respectively Rna14 or Pcf11 
normalized to RNAPII using a TAP-tagged version of those factors at nc-tgp1 and tgp1 loci in slow 
mutant relative to a WT strain. (D) Same as B and C but using an HTP-tagged version of Seb1. Error 
bars represent standard error for 3 independent experiments. Non-normalized profiles are available 
in Supplemental figure 3 and Supplemental figure 4. (E) Western blot analyses of chromosomally-
tagged Rna14-TAP, Pcf11-TAP and Seb1-HTP in WT and slow mutant expressing cells. WT no 
tagged Rna14, Pcf11 and Seb1 were used as negative controls. Tubulin was used as loading controls.  
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3.2. Altered distribution of Ser2 CTD phosphorylation between proximal and 
distal PAS of nc-tgp1 in rpb1 slow mutant 
Several studies have examined the interplay between the status of CTD 
phosphorylation and 3′ end processing/transcription termination (Buratowski, 2009; 
Heidemann et al., 2013; Larochelle et al., 2018; Lunde et al., 2010; Wittmann et al., 2017). 
Since a correlation has been made between genome-wide ChIP-seq profiles of transcription 
termination factors and Ser2, we were wondering if this residue was also following the same 
redistribution pattern as observed previously for Rna14, Pcf11 and Seb1 (3.1). 
 
Averaging ChIP assays signal across nc-tgp1 and tgp1 loci revealed a Ser2-P pattern 
similar to the ones for 3’end processing factors (Supplemental Figure 5B), as well as after 
normalizing to RNAPII density because this phosphorylation occurs directly on the C-
terminal domain of RNAPII Rpb1 subunit (Supplemental Figure 5C). Interestingly, when 
ChIP assay profiles from independent biological replicates were analyzed in the slow mutant 
relative to the WT, a noticeable decrease of Ser2-P signal was present near the PAS2 (Figure 
12B, PCR target number 6). In contrast, an important increase of Ser2-P signal was found 
around the PAS1 (Figure 12B, PCR targets number 1-3). Surprisingly though, similar levels 
of Ser2-P were assessed by western-blot between a WT strain and a slow mutant (Figure 
12C), suggesting that it is a local redistribution of Ser2-P from distal to proximal PAS instead 
of a global increase of Ser2-P in the slow mutant. 
 
Altogether, these results show that there is a relative increased amount of CTD 
phosphorylated serine2 around the PAS1 of nc-tgp1 in the slow mutant. In fact, it correlates 
very well with the relative increased abundancy of 3’end processing factors who would be 
be most likely to be recruited due to the augmentation of this CTD modification. 
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Figure 12. Increased levels of Ser2 CTD phosphorylation at the proximal nc-tgp1 PAS 
and concomitant decrease at the distal nc-tgp1 PAS in the rpb1 slow mutant. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The eight PCR amplicons are represented by black 
horizonal segments numbered from 1 to 8. (B) Average ChIP assays signal of Ser2 CTD 
phosphorylation at nc-tgp1 and tgp1 loci in slow mutant relative to a WT strain. (C) Western blot 
analysis of total Ser2 CTD phosphorylation in a WT strain and slow mutant. 
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Discussion 
The goal of this study was to investigate the consequences of transcription elongation 
rate on gene expression in the fission yeast. So far, studies in mammalian cells or in the 
budding yeast have focused on the impact of transcription elongation rate on splicing or 
transcription termination and the role of transcription factors on those steps, but it is still 
unknown how transcription elongation rate mechanistically influences gene expression, and 
even less in the fission yeast. 
 
We used a direct approach to modify the transcription elongation rate. Thanks to Dr. 
Julien Berro’s team (Yale University), the genome editing CRISPR/Cas9 system in S. pombe 
has been used to generate a Rpb1 mutant strain with a specific and largely studied mutation 
in the trigger loop (Figure 1, N494D) resulting in a RNAPII complex ongoing a slow 
transcription elongation rate in vitro (Kaplan et al., 2012 ; Hazelbaker et al., 2013 ; 
Aslanzadeh et al., 2018). Using this model, genome-wide gene expression was carried out 
on the slow mutant by ribo-depleted bulk RNA-seq and differentially compared to a WT 
strain. 
 
 Since transcription is a major step in gene expression, we were not surprised to obtain 
hundreds of genes significantly differentially expressed between the WT and the Rpb1 slow 
mutant (Figure 7A). In addition, after performing gene set enrichment analysis, the up-
regulated genes showed stress response enriched categories (Figure 7B), which can explain 
the slow growth phenotype (Supplemental Figure 1) and the increased sensitivity to DNA 
damage and osmotic stress (Supplemental Figure 2).  
 The most significant up-regulated gene in the slow mutant was tgp1, whose product 
is a transmembrane glycerophosphate transporter. It is activated in response to phosphate 
starvation with pho1 and pho84. Surprisingly, pho84 showed similar expression levels 
between the WT and the slow mutant but more importantly, all the strains have been grown 
in the same conditions, excluding a phosphate starvation response towards a molecular event 
related to a slow transcription elongation rate. In fact, tgp1 is only 6-fold more expressed in 
the slow mutant compare to the WT (Supplementary Table 2), whereas it is overexpressed 
30 times more in phosphate lacking media (Ard et al., 2014). This 6-fold change has been 
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confirmed by RT-qPCR where we also discovered an under expression of the upstream long 
non coding RNA named nc-tgp1 (Figure 7B). This correlates with the non-coding RNAs 
enriched categories for the down-regulated gene list (Figure 7C). This observation validated 
the hypothesis that tgp1 is not up-regulated by the lack of phosphate in the media but actually 
from the down regulation of its cis regulatory lncRNA nc-tgp1 because it has been 
demonstrated that deletion of nc-tgp1 derepresses tgp1 (Ard et al., 2014). 
 
 Due to the recent discovery of a proximal polyadenylation signal (PAS) at the nc-tgp1 
locus (Sanchez et al., 2018), we next asked if an early alternative polyadenylation event of 
nc-tgp1 could be a consequence of a slow transcription elongation rate. Indeed, when 
combining our RNA-seq data with published 3’READS data (Liu et al., 2017), the proximal 
PAS appeared to be preferentially used genome-wide (Figure 8A) as well as at the nc-tgp1 
locus (Figure 8B, PAS1). 
 In order to gather more evidence that the PAS1 (proximal) of nc-tgp1 is favored over 
the PAS2 (distal), different ChIP assays were carried out in the slow mutant and the WT. 
Here we compare the abundance of different targets between the slow mutant and the WT, it 
is important to normalize the data relative to the WT to really appreciate the differences. 
First, RNAPII density showed a faster decrease in the slow mutant when approaching the 
PAS1 (Figure 10C). Second, Pho7 binding is 3-fold greater in the slow mutant around tgp1 
promoter (Figure 10D). Together, these results confirm the transcriptional interference from 
the overlap between nc-tgp1 template and tgp1 promoter. In other words, a slow transcription 
elongation rate could favor transcription termination at PAS1 making room for Pho7 to bind 
at tgp1 promoter. 
 In addition, a pattern of redistributed transcription termination factors from PAS2 to 
PAS1 was observed (Figure 11). Since those proteins are indirectly recruited by the RNAPII, 
it was important to normalize the abundancy of those factors by the density of RNAPII. 
Furthermore, this result has been correlated with the similar redistribution of CTD 
phosphorylated serine 2 (Figure 12) known to be enriched when the RNA polymerase II is 
approaching a transcription termination site (Larochelle et al., 2018) and acting in the 
recruitment of 3’end processing factors (Lunde et al., 2010; Wittmann et al., 2017). 
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Altogether those results give rise to the following model (Figure 13). Based on the 
study of Dr Ryan Ard (Ard et al., 2014), in phosphate-replete condition transcription of tgp1 
is not desired, so the upstream transcription of nc-tgp1 continues within tgp1 gene 
downstream resulting in transcription interference of tgp1 in cis (Figure 13A). In that way, 
nc-tgp1 transcription termination either occurs at PAS2 or PAS3 (Supplementary Figure 4, 
5 and Figure 13A), both cases leading to the repression of tgp1. On one hand, if nc-tgp1 
transcription terminates at PAS2, the transcription termination machinery for nc-tgp1 would 
compete with the transcription initiation machinery for tgp1 by steric hindrance. On the other 
hand, if nc-tgp1 transcription readthrough terminates at PAS3 it results in an unstable 
transcript fusion of nc-tgp1 and tgp1 (Sanchez et al., 2018). However, the mechanism of 
decision making between PAS2 and PAS3 remains unknown. 
More recently, the study of Dr Ana Sanchez allowed the discovery of a short form of 
nc-tgp1 (Sanchez et al., 2018) related to an APA site upstream of the well-known PAS2 
(Figure 13B, PAS1). Even though the cis and trans factors that control nc-tgp1 transcription 
are presently unknown, the usage of the N494D slow mutant in my work brought new 
insights of tgp1 regulation. The correlation of the relative increased abundancy of Ser2-P 
with transcription termination factors at PAS1 (Figure 11 and 12) as well as the relative 
decreased density of RNAPII when approaching PAS1 (Figure 10C) and the increased 
binding of Pho7 around tgp1 promoter (Figure 10D) bring the conclusion that a slow 
transcription elongation rate favors transcription termination at the proximal PAS1. 
Consequently, this discovery explains why, both RNAPII density at tgp1 locus (Figure 10) 
and mRNA level are increased for tgp1 in the slow mutant (Figure 9). In other words, the 
usage of the slow mutant in this study potentially mimic the consequences of phosphate 
starvation in a WT strain by terminating earlier nc-tgp1 at PAS1 and allowing the activation 
of tgp1 downstream. 
 
Although the function of most lncRNAs is unknown, the number of characterized 
lncRNAs is growing and many publications suggest that they are important for regulating 
negatively or positively gene expression in cis or in trans involved in development, 
differentiation and human disease (Taft et al., 2010; Wilusz et al., 2009). One of the modes 
of cis regulation by lncRNAs refers to transcription-mediated silencing or transcriptional 
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interference. It involves the process of transcription itself when the transcription of one gene 
can repress in cis the functional transcription of another gene by influencing enhancer or 
promoter activity or by blocking RNAPII elongation, splicing or polyadenylation (Palmer et 
al., 2011; Shearwin et al., 2005). The most common reports of transcriptional interference 
concern an overlapped promoter, just like our case of nc-tgp1 and tgp1, but studies have 
focused the molecular mechanisms underlying interference on the promoter state of the gene 
downstream. They demonstrated the consequences of transcriptional interference from 
upstream lncRNAs on promoter nucleosome repositioning (Martens et al., 2004) and 
promoter histone modifications (Houseley et al., 2008; van Werven et al., 2012) from the 
point of view of RNAPII acting as a carrier of chromatin modifying enzymes. However, 
based on my findings, I bring a new mechanism of gene regulation through transcription 
interference involving a slow transcription elongation rate favorizing a proximal transcription 
termination site on the gene model tgp1. 
 
 
Figure 13. Model of tgp1 regulation by Rpb1 N494D slow mutant through nc-tgp1 
transcription in phosphate-replete growth. 
(A) In a WT strain, transcription begins at nc-tgp1 promoter and either terminates at PAS2 or PAS3 
for the readthrough. (B) In a slow mutant, transcription begins at nc-tgp1 promoter and terminates at 
the APA site PAS1 allowing Pho7 to bind to tgp1 promoter and induces its transcription.  
The transcription by RNAPII is represented in orange. The transcription termination events are 
represented by the correlation of Ser2-P abundancy in blue with the recruitment of transcription 
termination factors. The different forms of nc-tgp1 RNA (Sanchez et al., 2018) are represented in red 
and tgp1 RNA in blue. 
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Conclusion and perspectives 
Transcription is a key process for gene expression. By slowing down the transcription 
elongation rate we significantly changed the gene expression profile of 876 genes in the 
fission yeast. Then, downstream analyses oriented the study to focus on the tgp1 gene, coding 
for a transmembrane glycerophosphate transporter, which was the most significant up-
regulated gene in the slow mutant. By combining studies from the literature and ChIP assays 
we demonstrated that the long non-coding RNA nc-tgp1, known to represses tgp1 in cis 
through transcription interference, is actually being terminated prematurely using the 
proximal polyadenylation signal (PAS). This early termination event leads to the opportunity 
of the transcription factor Pho7 to directly bind the chromatin at tgp1 promoter. 
Consequently, tgp1 is over expressed when the amount of phosphate is actually the same 
between the slow mutant and the WT. In summary, the use of a slow rpb1 allele in this study 
allowed the discovery of a new regulatory mechanism for tgp1 and illustrates the molecular 
events at this locus in the context of phosphate starvation. 
 
However, some questions remain unanswered. In particular, if nc-tgp1 is being 
terminated prematurely in the slow mutant, we would expect an enrichment of this short form 
of non-coding RNA. We would like to investigate the short form of nc-tgp1 but studying 
ncRNAs in yeast is problematic. In yeast, the majority of these ncRNAs, called cryptic 
unstable transcripts (CUTs) due to their unstable nature, are retained in the nucleus and 
degraded by the exosome, a major 3′ to 5′ RNA degradation machinery that plays a key role 
in RNA metabolism, RNA processing and RNA surveillance, and is essential for the viability 
of eukaryotic cells (Wyers et al., 2005). One of the exosome subunits is Rrp6, which is 
exclusively associated with the nuclear form of the exosome and is required for the rapid 
nuclear degradation of CUTs. However, it has been shown that CUTs were stabilized by the 
deletion of rrp6 (Wyers et al., 2005 ; Davis, Ares, 2006). Furthermore, the nuclear exosome 
is also involved in the degradation of a group of meiotic mRNAs during vegetative growth. 
The targeting of these mRNAs to the nuclear exosome requires the RNA-binding protein 
Mmi1, which recognizes a specific sequence motif (determinant of selective removal or 
DSR-sequence) on meiotic mRNAs and therefore will indirectly recruit the exosome. In fact, 
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nc-tgp1 displays a DSR motif within its own locus and becomes detectable in rrp6Δ or 
mmi1Δ cells (Sanchez et al., 2018). 
Moreover, the proximal polyadenylation signal of nc-tgp1 has been described as a 
“weak” site due to variation in the consensus sequence (Sanchez et al., 2018). Thus, it would 
be interesting to insert by CRISPR a “strong” polyadenylation signal instead of the weak one 
in order to potentially rescue the overexpression of tgp1 observed in the slow mutant. 
Finally, some mutations in the trigger loop of Rpb1 have been characterized to 
accelerate the transcription elongation rate (Figure 1B, Kaplan et al., 2012). Therefore, if a 
slow transcription elongation rate shows an overexpression of tgp1 by favoring the use of the 
proximal PAS, the experiment described here could be repeated using a fast transcription 
elongation mutant. Indeed, in phosphate starvation, when the proximal PAS would be 
preferentially used to express tgp1, we could imagine the distal PAS being favored in the fast 
mutant compare to the WT. Or on the contrary, in phosphate repleted media, a reduction of 
the use of the proximal PAS in the fast mutant compare to the WT. 
 
Overall, this study only begins to further our understanding of how transcription 
elongation rate influences gene expression. It is a crucial step in gene expression of every 
organism and the discoveries related to the consequences on gene expression will be of great 
value to the scientific community. 
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Supplementary figures 
 
Supplementary Figure 1. Rpb1 slow mutants show reduced growth in minimal media. 
Yeast strains were analyzed in liquid rich medium (YES) or synthetic medium (EMM) with OD 
monitoring in a microplate reader at 30°C. For the slow mutants, two biological replicates harboring 
the same mutation from the genome edition have been used in this experiment. Similar growth curves 
were observed in YES whereas the slow mutants showed a slower growth rate in EMM. Those 
observations have shown reproducibility for two liquid growth assay experiments. Values represent 
the mean of three technical replicates. 
 
 
 
Supplementary Figure 2. Sensibility of WT and slow mutant strains to DNA damage 
and osmotic stress. 
Ten-fold serial dilutions of wild-type (FBY2323) and slow mutants (FBY2324 and FBY2325). Cells 
were spotted on rich media (YES) with or without hydroxyurea or KCl at indicated concentrations. 
 
  
48 
48 
 
Supplementary Figure 3. Consistent binding profiles of 3’end processing factors at 
PAS1 and PAS2. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The eight PCR amplicons are represented by black 
horizonal segments numbered from 1 to 8. (B-C) Average ChIP assays profile using a TAP-tagged 
version of respectively Rna14 or Pcf11 in a WT strain and slow mutant. (D) Average ChIP assays 
profile using an HTP-tagged version of Seb1 in a WT strain and slow mutant. Error bars represent 
standard error for 3 independent experiments. 
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Supplementary Figure 4. Binding profiles of Rna14, Pcf11 and Seb1 normalized by 
RNAPII show a maximum binding around PAS2. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The eight PCR amplicons are represented by black 
horizonal segments numbered from 1 to 8. (B-C) Average density of respectively Rna14 or Pcf11 
relative to RNAPII using a TAP-tagged version of those factors in a WT strain and slow mutant. (D) 
Same as B and C but using an HTP-tagged version of Seb1. Error bars represent standard error for 3 
independent experiments. 
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Supplementary Figure 5. RNAPII Ser2 CTD phosphorylation colocalize with 3′ end 
processing factors at nc-tgp1 locus. 
(A) The tandem nc-tgp1-tgp1 locus is shown with transcription start sites indicated by black arrows 
indicating the direction of transcription and the tgp1 ORF represented by a white rectangle. The 
different PAS are depicted by blue vertical arrows. The eight PCR amplicons are represented by black 
horizonal segments numbered from 1 to 8. (B) Average ChIP assays profile Ser2-P at nc-tgp1 and 
tgp1 loci in a WT strain and slow mutant. (C) Average ChIP assays profile Ser2-P normalized to 
RNAPII density at nc-tgp1 and tgp1 loci in a WT strain and slow mutant. Error bars represent standard 
error for 3 independent experiments. 
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Supplementary tables 
Supplementary Table 1. List of S. pombe strains used in this study 
 
 
Supplementary Table 2. List of 382 up-regulated genes in the slow mutants 
gene_symbol Log2_FC deseq.adj.pvalue WT.norm Slow1.norm Slow2.norm 
tgp1 2.498 2.3E-23 3321 18315 19211 
mfm3 2.704 2.9E-15 99 627 659 
mag2 2.663 2.2E-14 93 635 545 
SPBCPT2R1.07c 2.173 2.2E-14 414 1995 1741 
mug14 1.78 2.6E-14 642 2223 2188 
fkh1 1.517 2.2E-11 4107 11950 11557 
bit2 2.154 1.2E-10 139 638 601 
SPAPB15E9.02c 1.429 6.8E-10 858 2283 2336 
SPAC6G10.06 2.529 1.5E-09 100 627 523 
SPAC1002.01 1.542 2.6E-09 520 1581 1449 
eic2 1.538 0.000000003 521 1563 1466 
mfm1 2.869 5.3E-09 1553 10177 12527 
gpd3 1.974 0.000000027 2915 10509 12398 
SPMITTRNAALA.01 1.995 0.000000059 115 431 484 
Name Genotype Reference 
FBY2323 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ (Fernandez and Berro, 
2016) 
FBY2324 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) (Fernandez and Berro, 
2016) 
FBY2325 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) (Fernandez and Berro, 
2016) 
FBY2538 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ Seb1-HTP::kanMX6 This study 
FBY2541 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) Seb1-HTP::kanMX6 This study 
FBY2542 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ Pho7-TAP::natMX6 This study 
FBY2545 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) Pho7-TAP::natMX6 This study 
FBY2549 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ Rna14-TAP::natMX6 This study 
FBY2551 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) Rna14-TAP::natMX6 This study 
FBY2556 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ Pcf11-TAP::natMX6 This study 
FBY2557 h- ade6-M216 leu1-32 ura4-D18 his3-D1 fex1Δ fex2Δ rpb1 (N494D) Pcf11-TAP::natMX6 This study 
  
52 
52 
SPAC3G9.11c 1.224 0.000000077 1088 2420 2663 
mam2 1.098 0.00000025 2849 6409 5788 
swi5 1.075 0.00000027 2072 4255 4472 
SPAC26A3.14c 1.485 0.00000031 5469 14212 16403 
SPMITTRNAILE.01 1.816 0.00000036 138 504 469 
isp6 1.237 0.00000044 5987 15018 13203 
ste6 1.1 0.00000049 3341 7338 6989 
tum1 1.25 0.00000057 753 1781 1799 
SPMITTRNATYR.01 1.645 0.00000063 206 632 654 
SPBP8B7.32 1.086 0.00000085 3461 7420 7275 
SPNCRNA.1348 2.229 0.000001 47 229 214 
map1 1.023 0.0000011 1988 3913 4166 
gal10 1.231 0.0000015 683 1662 1545 
srp7 1.776 0.0000017 13571 44034 48921 
cox6 1.358 0.0000019 9526 23791 25050 
SPBC1685.12c 1.197 0.000002 767 1731 1784 
SPNCRNA.134 1.27 0.0000032 533 1319 1253 
SPAC186.05c 2.287 0.0000042 76 333 411 
SPBPB21E7.04c 1.918 0.0000044 74 294 265 
SPNCRNA.679 1.31 0.0000067 439 1017 1160 
ypt1 1.135 0.0000067 7309 16536 15578 
SPCC1442.14c 1.033 0.0000074 1201 2426 2489 
spo13 1.636 0.0000096 142 414 472 
SPAPJ695.02 2.849 0.000012 13 95 92 
SPNCRNA.920 1.484 0.000012 312 801 942 
SPAC31G5.21 0.981 0.000012 1426 2692 2938 
arc5 0.949 0.000014 1625 3055 3220 
SPBPB2B2.05 1.126 0.000015 732 1579 1618 
atf1 0.994 0.000015 4538 9029 9054 
apc13 1.347 0.000016 307 812 751 
  
53 
53 
SPAC9E9.02 1.321 0.000016 352 947 812 
SPACUNK4.16c 1.439 0.000019 13326 35930 36311 
snx3 1.073 0.000029 2943 6610 5774 
mug143 1.407 0.000042 370 1065 900 
mug190 0.997 0.000059 4935 9218 10477 
usp109 0.883 0.000059 2975 5361 5613 
rgs1 0.876 0.000062 2927 5300 5445 
sdh2 1.122 0.000063 9618 20007 21853 
SPBC29A3.03c 0.881 0.000063 1647 3052 3014 
SPNCRNA.1114 1.422 0.000078 184 475 512 
SPNCRNA.1697 1.091 0.00008 592 1324 1198 
cid2 0.888 0.000085 1414 2764 2469 
SPAC17C9.11c 0.889 0.000092 3670 6576 7021 
apc15 1.021 0.000094 797 1599 1635 
syf2 0.853 0.000096 1861 3262 3460 
snR94 1.306 0.000099 3673 9839 8322 
SPATRNAPRO.02 2.429 0.00012 17 95 91 
cta3 2.22 0.00014 745 3048 3900 
bis1 0.95 0.00016 1013 1871 2043 
SPAC4D7.02c 0.893 0.00016 1215 2366 2148 
lsm6 0.864 0.00018 4135 7514 7535 
opi10 1.153 0.00019 406 877 929 
lsd90 0.993 0.00019 776 1531 1558 
ste11 0.897 0.00022 6396 12479 11338 
mug191 0.811 0.00022 2484 4108 4611 
cox13 1.032 0.00025 9977 19589 21227 
SPNCRNA.1294 1.147 0.00026 374 830 826 
ste4 0.83 0.00029 3753 6535 6807 
SPAC144.16 0.801 0.00032 1851 3138 3315 
ret3 1.098 0.00042 12456 25370 27949 
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54 
SPAC17A5.19 1.081 0.00042 451 925 982 
aif1 0.777 0.00044 2129 3511 3788 
SPAC17G6.07c 0.871 0.00046 3562 6098 6929 
SPNCRNA.713 0.96 0.00057 708 1342 1411 
snoR02 1.373 0.00059 680 1598 1925 
mug2 0.928 0.00059 814 1512 1584 
SPNCRNA.1648 0.773 0.00059 1744 3041 2919 
SPNCRNA.388 0.776 0.00061 1818 3001 3225 
erp5 0.789 0.00065 3531 5751 6454 
SPBC27B12.14 0.755 0.00066 1814 3239 2881 
SPNCRNA.1159 1.28 0.00068 175 424 424 
ppk31 0.918 0.00071 813 1489 1583 
acp1 0.799 0.00073 4444 7569 7900 
SPNCRNA.728 0.879 0.00076 955 1733 1779 
Tf2-6 1.099 0.00078 333 735 692 
ntp1 0.896 0.00078 8431 15203 16185 
SPATRNAVAL.04 2.787 0.00085 8 53 52 
SPBC36.02c 1.105 0.00087 1659 3282 3857 
SPAC22F8.05 0.806 0.00088 4997 8246 9228 
SPBTRNATRP.02 3.432 0.001 4 40 55 
atp15 1.265 0.001 1876 4100 4918 
mbx2 0.746 0.001 1830 3037 3101 
gcg1-antisense-2 1.293 0.0011 151 348 393 
SPCC1919.07 1.357 0.0012 1171 2712 3290 
nxt2 0.738 0.0012 1954 3101 3416 
mug16 0.965 0.0013 534 1069 1016 
SPNCRNA.304 0.807 0.0013 1158 2062 1991 
alp31 0.745 0.0013 1760 2824 3078 
SPAC222.18 0.738 0.0013 1637 2840 2621 
idh1 0.796 0.0014 6467 11168 11291 
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SPBPB2B2.16c 2.138 0.0015 41 204 155 
SPBTRNALEU.05 2.319 0.0016 13 68 61 
SPCC306.08c 0.751 0.0017 4108 6521 7312 
spn6 0.976 0.0018 481 920 971 
SPNCRNA.901 1.321 0.002 116 268 311 
SPNCRNA.111 1.003 0.002 13772 26279 28920 
mrp10 0.902 0.002 2549 4420 5109 
SPNCRNA.905 0.798 0.002 1223 2269 1982 
SPAC343.04c 0.783 0.002 6217 10135 11264 
rum1 0.701 0.002 3077 5035 4966 
SPBC18H10.05 0.742 0.0021 1550 2438 2749 
SPAC607.08c 0.728 0.0022 2288 3560 4021 
SPNCRNA.875 0.684 0.0022 2295 3715 3659 
sft1 0.868 0.0023 711 1327 1269 
SPNCRNA.855 2.084 0.0024 17 82 64 
arp2 0.906 0.0024 11573 21002 22359 
SPBTRNAPRO.04 3.222 0.0025 8 59 84 
SPAC1F12.10c 0.889 0.0025 1617 2777 3212 
lsm3 0.764 0.0025 4557 7244 8237 
SPNCRNA.774 1.338 0.0026 99 237 261 
pnn1 0.717 0.0026 1619 2592 2730 
SPAC222.17 0.695 0.0026 1843 2965 3001 
gal7 0.684 0.0027 1919 3119 3047 
SPNCRNA.794 1.157 0.0028 178 400 393 
SPNCRNA.1169 1.141 0.0028 192 418 428 
SPAC17G6.03 0.685 0.0028 3474 5680 5488 
dsc3 0.686 0.0029 3776 6315 5836 
ste7 1.017 0.0031 1567 2910 3435 
SPCC320.04c 0.746 0.0031 6775 11568 11152 
SPAC27F1.10 1.566 0.0032 48 129 158 
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56 
shg1 0.692 0.0032 1655 2737 2612 
SPBPB2B2.11 1.104 0.0033 211 448 459 
SPAC4G8.03c 0.702 0.0033 1664 2598 2816 
SPNCRNA.1454 1.119 0.0035 190 425 398 
SPCC1739.08c 0.994 0.0037 306 653 567 
SPBC1683.12 0.726 0.0037 1399 2200 2429 
SPAC19A8.07c 0.675 0.0037 3293 5057 5459 
SPNCRNA.569 1.2 0.0038 621 1291 1564 
SPNCRNA.1391 0.897 0.0039 605 1215 1037 
thp1 0.72 0.0039 3292 5081 5770 
mad2 0.658 0.0039 2007 3228 3107 
dph4 0.647 0.0039 2424 3861 3731 
spk1 0.65 0.0041 3371 5589 4991 
SPAC19G12.09 0.649 0.0041 2860 4521 4446 
SPBC1604.16c 0.855 0.0043 618 1119 1115 
cid13 0.637 0.0043 2301 3733 3422 
mhf1 0.839 0.0046 672 1158 1249 
SPCC794.15 0.689 0.0046 1519 2452 2447 
SPAC3F10.12c 0.654 0.0046 3081 4716 4981 
bet5 0.786 0.0047 871 1471 1535 
kms1 0.662 0.0047 1851 2881 2979 
aca1 0.641 0.0047 3119 4990 4736 
Tf2-4 3.051 0.005 246 2445 1637 
SPNCRNA.1067 1.309 0.005 85 207 212 
SPAC186.04c 2.895 0.0051 14 86 123 
atp20 0.752 0.0051 7981 12617 14259 
SPBC119.03 0.674 0.0051 1666 2567 2750 
SPNCRNA.989 1.243 0.0052 104 243 249 
tam9 0.733 0.0052 1058 1865 1649 
oma1 0.708 0.0052 1371 2114 2369 
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SPAC11D3.04c 0.698 0.0052 1386 2226 2273 
SPAC15A10.07 0.694 0.0052 2642 4007 4547 
SPAC12G12.11c 0.664 0.0052 3756 5696 6208 
SPAC13F5.07c 1.14 0.0057 153 311 364 
SPAC977.13c 1.454 0.0059 51 142 140 
SPAC1B3.20 0.893 0.0059 450 829 841 
pvg2 0.616 0.0059 2619 4194 3829 
SPRRNA.52 1.827 0.006 316 967 1276 
SPBPB2B2.06c 0.83 0.006 12623 23320 21565 
SPMITTRNAMET.02 1.339 0.0062 71 178 179 
SPNCRNA.1553 1.218 0.0063 105 244 244 
spc24 0.665 0.0063 4835 7681 7656 
SPBC1683.01 0.66 0.0063 4227 7104 6248 
SPNCRNA.220 1.944 0.0065 17 67 66 
mfm2 0.902 0.0065 5916 11981 10132 
SPCTRNALYS.12 2.893 0.0066 4 30 35 
SPNCRNA.648 1.608 0.0066 84 223 287 
SPNCRNA.519 1.028 0.0066 214 452 421 
SPNCRNA.1565 0.914 0.0066 385 710 744 
SPBC15D4.08c 0.897 0.0068 425 759 824 
spc19 0.745 0.007 897 1537 1470 
mei2 0.976 0.0072 17194 31196 36431 
SPBC4B4.12c 0.649 0.0072 1601 2543 2477 
SPNCRNA.1473 0.924 0.0073 346 648 664 
stc1 0.836 0.0074 581 966 1110 
SPNCRNA.1666 1.183 0.0076 110 250 251 
cmc4 0.772 0.0076 724 1301 1171 
isd11 0.618 0.0076 2649 3857 4275 
SPAC664.13 0.846 0.0077 497 914 872 
rsm27 0.612 0.008 3363 5242 5035 
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SPCTRNAGLN.06 2.853 0.0081 4 29 35 
ats1 0.669 0.0081 5969 9242 9733 
gos1 1.172 0.0082 1848 3742 4588 
SPNCRNA.1046 1.071 0.0087 170 330 386 
ght3 1.447 0.0088 179 548 428 
SPCC1259.16 0.725 0.0089 1348 2075 2382 
btn1 0.925 0.0094 320 570 646 
oct1 0.606 0.0095 3326 5014 5115 
SPAC29E6.09 0.686 0.0097 1217 1870 2048 
pet117 0.698 0.0099 1134 1739 1942 
mug35 1.114 0.01 1944 4645 3772 
SPNCRNA.623 1.079 0.01 635 1212 1472 
SPNCRNA.909 1.027 0.01 187 370 394 
SPNCRNA.1350 0.965 0.01 243 471 478 
SPSNORNA.54 0.642 0.01 1582 2324 2617 
SPBC26H8.12 0.588 0.01 3095 4789 4515 
SPATRNAVAL.02 3.017 0.011 3 25 29 
SPNCRNA.1691 1.157 0.011 105 231 237 
SPNCRNA.993 1.103 0.011 133 270 301 
SPNCRNA.536 0.999 0.011 212 389 460 
SPAC105.02c 0.829 0.011 9405 15389 18021 
tam7 0.73 0.011 804 1398 1269 
SPNCRNA.841 0.647 0.011 1430 2156 2323 
orc6 0.645 0.011 1477 2219 2403 
SPNCRNA.976 1.049 0.012 149 323 293 
SPBTRNAPRO.07 1.899 0.013 30 96 129 
SPNCRNA.621 1.111 0.013 543 1054 1293 
mrpl28 1 0.013 5682 10294 12429 
SPNCRNA.1617 0.986 0.013 193 384 379 
rpl4102 0.932 0.013 3681 6403 7648 
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wtf17 0.873 0.013 446 750 886 
Tf2-10 0.852 0.013 365 679 639 
atp16 0.71 0.013 7899 13872 11968 
SPBC530.07c 0.663 0.013 7984 12516 12769 
new13 0.653 0.013 1259 1963 1996 
SPAC186.06 2.258 0.014 16 64 90 
SPNCRNA.1035 1.386 0.014 319 732 936 
SPAC513.02 1.018 0.014 161 332 319 
mrps16 0.958 0.014 2101 3708 4457 
SPAC56F8.13 0.842 0.014 394 687 727 
SPBC19G7.19 0.599 0.014 1594 2535 2293 
rlp1 0.575 0.014 3653 5649 5236 
ini1 0.84 0.015 770 1264 1492 
SPNCRNA.499 0.818 0.015 2199 4204 3548 
mim1 0.779 0.015 2486 3934 4596 
SPCC16A11.15c 0.746 0.015 618 1082 989 
SPNCRNA.1495 1.157 0.016 119 237 294 
pol4 0.848 0.016 332 635 559 
SPNCRNA.1518 0.7 0.016 1214 1832 2114 
rec11 0.675 0.016 961 1569 1500 
SPAC1687.21 0.617 0.016 6974 11095 10294 
SPCC794.04c 0.587 0.016 1692 2603 2480 
inv1 1.371 0.017 560 1634 1262 
atp18 1.34 0.017 1172 2606 3333 
fbp1 0.911 0.017 222 455 379 
SPMIT.03 0.786 0.017 15485 27549 25858 
hht2 0.662 0.017 9472 15338 14629 
ins1 0.56 0.017 2152 3151 3196 
coq7 0.553 0.017 3265 5031 4547 
SPBC216.03 0.545 0.017 2309 3567 3170 
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60 
SPNCRNA.1385 1.233 0.018 67 141 177 
SPNCRNA.1477 0.828 0.018 355 642 620 
ptc1 0.821 0.018 2778 4500 5321 
SPNCRNA.1214 0.746 0.018 563 991 897 
mot2 0.696 0.018 8875 13336 15413 
SPAC6G9.16c 0.675 0.018 900 1425 1450 
SPCC330.03c 0.646 0.018 1146 1713 1874 
SPNCRNA.1011 0.616 0.018 1256 2016 1832 
SPNCRNA.1279 0.573 0.018 1956 2790 3030 
SPAC17C9.14 0.553 0.018 3261 4892 4674 
SPNCRNA.1614 1.202 0.019 67 161 150 
SPBC83.13 0.753 0.019 14847 25939 24120 
erp2 0.609 0.019 6426 9465 10140 
ubp8 0.552 0.019 2537 3625 3814 
SPMIT.02 1.215 0.02 31748 75188 72254 
ecl3 1.176 0.02 1368 3451 2728 
SPCC663.18 0.563 0.02 3814 5510 5757 
SPAC23C4.04c 0.983 0.021 563 1004 1223 
ykt6 0.638 0.021 8297 12060 13760 
SPBC12C2.04 0.612 0.021 3831 5468 6240 
SPBC609.01 0.546 0.021 2065 3085 2944 
SPNCRNA.1556 1.118 0.022 85 191 176 
SPNCRNA.626 1.078 0.022 525 990 1226 
SPNCRNA.1472 0.993 0.022 149 281 312 
SPBC25B2.10 0.859 0.022 2287 3780 4516 
gdh2 0.819 0.022 18456 34882 30226 
SPAC6C3.05 0.782 0.022 466 741 860 
fsv1 0.773 0.022 1061 1966 1660 
SPNCRNA.1496 0.765 0.022 449 795 729 
dak1 0.621 0.022 7549 10939 12288 
  
61 
61 
sgt1 0.552 0.022 2026 2878 3061 
slm1 0.547 0.022 3395 4850 5071 
ace2 0.86 0.023 1055 1744 2086 
bet1 0.738 0.023 537 906 886 
mug37 0.671 0.023 890 1523 1309 
mug185 0.543 0.023 2025 2954 2948 
SPCTRNAALA.12 2.944 0.024 8 46 71 
SPAC16C9.01c 0.88 0.025 1787 2988 3591 
dli1 0.855 0.025 259 470 467 
SPNCRNA.607 0.806 0.025 314 591 506 
SPBC651.02 0.605 0.025 1134 1832 1615 
SPACUNK4.15 0.657 0.026 843 1328 1329 
SPAPB17E12.09 1.314 0.027 41 108 94 
SPCC63.05 0.838 0.027 3432 5589 6684 
meu25 0.798 0.027 336 589 580 
spt2 0.639 0.027 4274 6186 7129 
SPAC824.07 0.578 0.027 1395 2124 2041 
mcp5 0.569 0.027 1411 2213 1972 
SPNCRNA.1346 1.281 0.028 44 115 98 
SPAP27G11.16 1.005 0.028 118 238 235 
SPNCRNA.1589 0.813 0.028 314 535 568 
SPAC12G12.17 0.682 0.028 728 1098 1240 
meu23 0.625 0.028 1248 2065 1783 
SPBC21B10.02 0.576 0.028 1323 2064 1882 
SPAC23D3.17 1.467 0.029 1474 3505 4647 
SPNCRNA.923 1.374 0.029 223 501 655 
mug20 1.25 0.029 92 247 191 
SPBC19C7.04c 1.15 0.029 1901 4731 3708 
SPNCRNA.1489 0.708 0.029 575 925 954 
mug15 1.432 0.03 365 850 1121 
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SPAC11D3.19 1.391 0.03 277 829 625 
SPNCRNA.687 0.899 0.03 172 348 294 
cds1 0.516 0.03 3079 4353 4454 
SPBC2G2.17c 1.243 0.031 236 629 485 
eta2 1.188 0.032 800 1603 2043 
rec27 0.961 0.032 136 253 277 
img2 0.727 0.032 2158 3284 3862 
fum1 0.569 0.032 6899 9984 10486 
SPNCRNA.810 1.171 0.033 59 127 138 
SPCTRNAASN.05 1.557 0.034 21 56 71 
SPAC27E2.14 0.883 0.034 451 752 911 
hop1 0.856 0.034 213 387 385 
SPNCRNA.870 0.661 0.034 2154 3675 3136 
ubx2 0.524 0.034 1969 2752 2912 
spo12 0.573 0.035 1249 1887 1831 
SPBC428.10 0.52 0.035 3664 5033 5476 
SPBC11C11.01 0.508 0.035 3177 4416 4622 
SPNCRNA.1635 0.836 0.036 246 410 470 
SPNCRNA.788 0.8 0.036 297 564 468 
rpl4101 0.683 0.036 6505 9629 11262 
dak2 1.77 0.037 288 1151 813 
mug147 1.528 0.037 1059 2598 3510 
SPNCRNA.1383 0.968 0.037 123 226 256 
rga3 0.676 0.037 13432 19919 23012 
isa1 0.603 0.037 6358 10376 8944 
SPNCRNA.560 0.926 0.038 137 275 246 
SPNCRNA.698 0.782 0.038 286 507 476 
nas6 0.536 0.038 1716 2371 2606 
rpl3703 0.906 0.039 24785 42638 50245 
ade6 0.594 0.039 10539 16476 15330 
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63 
SPRRNA.53 1.4 0.04 29 66 87 
SPNCRNA.498 1.275 0.04 135 284 370 
spd2 1.018 0.041 26465 47648 59553 
SPCTRNAILE.09 2.166 0.042 6 27 32 
SPCC338.18 1.091 0.042 70 140 157 
tim11 0.638 0.042 8632 12416 14445 
hcn1 0.58 0.042 1041 1575 1537 
fra2 0.568 0.042 1104 1753 1519 
Tf2-12 1.067 0.043 73 152 153 
whi5 0.676 0.043 575 880 958 
mug133 0.727 0.044 365 618 591 
rpl35a 0.587 0.044 975 1471 1459 
spd1 0.568 0.044 2087 3315 2869 
pre3 0.557 0.044 7794 10914 12015 
grx4 0.536 0.044 6418 9047 9560 
rpn7 0.535 0.044 7147 10517 10195 
SPCC1827.05c 0.565 0.045 8373 11681 13095 
SPNCRNA.986 0.563 0.045 1090 1672 1549 
prf1 0.56 0.045 7975 11048 12475 
nse2 0.525 0.045 1564 2245 2256 
hcs1 0.522 0.045 6477 9513 9086 
mrp7 0.504 0.045 2027 2731 3018 
sno12 0.971 0.046 99 204 182 
SPNCRNA.1396 0.868 0.046 158 301 277 
lsm8 0.612 0.046 808 1221 1250 
ppk33 0.545 0.046 1279 1898 1834 
SPAC1002.20 2.03 0.047 8 31 31 
gmf1 0.807 0.047 1196 2298 1887 
SPNCRNA.1048 0.998 0.048 606 1075 1346 
mug136 0.697 0.048 444 703 738 
  
64 
64 
SPCTRNASER.13 2.245 0.049 5 25 27 
snoR69 1.041 0.049 78 144 178 
SPBC28E12.02 0.911 0.049 130 237 251 
SPNCRNA.1630 0.715 0.049 377 612 626 
SPNCRNA.572 0.88 0.05 145 271 261 
SPNCRNA.1613 0.811 0.05 206 369 352 
SPBC23G7.06c 0.799 0.05 6029 9506 11479 
SPAC24H6.08 0.584 0.051 945 1370 1465 
 
  
  
65 
65 
Supplementary Table 3. List of 494 down-regulated genes in the slow mutants 
gene_symbol Log2_FC deseq.adj.pvalue WT.norm Slow1.norm Slow2.norm 
SPBC660.05 -2.777 1.7E-46 4117 633 567 
urg2 -2.248 1.4E-24 2416 516 501 
urg1 -1.893 6.3E-22 3526 955 944 
str1 -1.611 4.4E-20 6639 2074 2273 
rpl2701 -1.591 3.5E-19 7025 2359 2305 
SPAC2H10.01 -2.518 5.9E-19 884 152 157 
SPCP20C8.02c -2.742 2.6E-18 609 97 84 
SPCC16C4.21 -1.838 2.7E-17 2484 759 630 
SPAC8E11.10 -1.456 8.4E-16 7078 2662 2497 
SPAC24H6.10c -1.506 2.9E-15 7391 2898 2304 
rps801 -1.97 3.2E-15 43857 11494 10895 
mcp7 -1.374 2.2E-14 5668 2213 2161 
ptr2 -1.374 5.8E-13 4045 1679 1439 
aat1 -1.303 5.8E-13 6801 2631 2881 
SPBC1683.05 -1.282 1.5E-12 6336 2555 2657 
SPBPB8B6.05c -1.522 1.9E-12 2483 896 833 
SPAC8C9.05 -1.284 8.5E-12 7925 3377 3131 
SPAC1039.02 -1.236 9.2E-12 5464 2255 2386 
pyp2 -1.547 3.6E-11 1818 611 634 
SPNCRNA.1235 -1.401 8.1E-11 2478 926 950 
SPAC4G9.22 -1.218 8E-10 3706 1740 1445 
rps2601 -1.554 9.2E-10 38979 12129 14427 
SPCC1884.01-
antisense-1 
-1.287 3.8E-09 2447 1003 1003 
rpl702 -1.345 4.8E-09 23479 10132 8358 
SPCP20C8.03 -3.207 6.4E-09 110 14 9 
SPNCRNA.1696 -1.341 0.000000015 1834 731 717 
rpl1601 -1.134 0.000000016 9395 4539 4020 
  
66 
66 
mfs2 -1.449 0.00000004 1314 545 416 
put4 -1.395 0.000000044 1339 474 545 
pac2 -1.065 0.000000044 7103 3540 3250 
SPAC3G6.05 -1.136 0.000000046 2992 1348 1375 
SPBC1271.04c -1.012 0.000000093 5775 2796 2933 
hem2 -1.086 0.00000013 11441 5395 5380 
frp1 -1.658 0.00000017 547 153 194 
SPCC320.08 -1.01 0.00000017 6906 3314 3545 
pus1 -0.981 0.00000023 5122 2517 2673 
SPNCRNA.1649 -1.97 0.00000027 268 54 82 
byr3 -1.084 0.00000027 13459 6413 6280 
SPBC646.07c -1.007 0.00000027 4196 2205 1968 
SPAC1B3.04c -1.246 0.00000037 1638 688 693 
sdh4 -1.034 0.00000039 10387 4916 5233 
alo1 -0.975 0.00000044 4205 2110 2169 
SPAC1039.01 -1.322 0.00000047 1221 466 511 
SPBC18H10.20c -1.153 0.00000068 22887 9867 10713 
SPCC584.16c -1.504 0.00000069 685 237 246 
SPNCRNA.877 -2.556 0.00000072 119 19 22 
pgt1 -0.993  0.0000009 9053 4477 4622 
SPAC29E6.07 -1.563 0.000001 545 178 191 
SPAC977.12 -0.998 0.000001 3386 1751 1638 
urg3 -0.931 0.0000011 5504 2795 2981 
SPBC1271.10c -1.058 0.0000014 2538 1219 1220 
rar1 -1.059 0.0000015 16101 7986 7468 
rrn3 -1.001 0.0000015 9951 5227 4716 
dsd1 -0.948 0.0000018 7355 3844 3779 
rpb6 -0.943 0.0000021 3913 2134 1935 
vht1 -1.261 0.0000023 34519 15434 13378 
SPNCRNA.655 -1.169 0.0000029 1506 650 689 
  
67 
67 
SPAC1565.05 -0.914 0.0000029 5811 3147 3022 
cdb4 -0.945 0.0000044 9851 4926 5311 
atx1 -0.894 0.0000044 4361 2336 2359 
cbf12 -0.903 0.0000048 6146 3385 3187 
thi9 -1.162 0.0000066 30549 13476 13834 
pog1 -0.873 0.0000067 5975 3082 3442 
SPCC1795.12c -0.933 0.0000068 9843 5060 5250 
dea2 -1.033 0.000011 2032 1008 978 
SPNCRNA.885 -1.249 0.000012 946 417 378 
SPAC2C4.05 -1.148 0.000012 5022 2548 1981 
SPCC584.13 -1.113 0.000012 1451 655 686 
rpc34 -0.967 0.000012 2533 1289 1303 
SPAC694.04c -0.881 0.000012 6621 3708 3482 
SPNCRNA.1531 -0.864 0.000014 4489 2619 2311 
SPNCRNA.1432 -1.606 0.000015 308 92 111 
SPBC365.16 -0.869 0.000015 7431 3911 4229 
SPAC869.02c -1.166 0.000016 1216 578 506 
SPAC2E1P3.05c -1.12 0.000016 1353 611 635 
SPAC1B3.13 -0.876 0.000016 7358 4086 3932 
sec2302 -0.854 0.000017 4216 2400 2263 
ade9 -0.882 0.000018 8126 4460 4361 
rlp24 -0.828 0.000024 5715 3102 3337 
eft202 -1.065 0.00003 16141 8617 6815 
SPCC1529.01 -0.823 0.00003 4986 2816 2822 
dph6 -0.829 0.000036 4380 2590 2341 
SPAC105.03c -0.828 0.000036 5651 3293 3072 
laf2 -1.108 0.000041 1869 975 758 
SPBC115.03 -0.961 0.000046 1987 985 1057 
SPNCRNA.142 -1.791 0.000047 183 54 51 
gcg1 -0.895 0.000056 2619 1416 1400 
  
68 
68 
fra1 -0.802 0.000059 5077 2940 2886 
new8 -1.23 0.000066 685 295 289 
rpl802 -0.835 0.000066 8191 4603 4580 
fmn1 -0.818 0.000069 6358 3814 3397 
asa1 -0.865 0.00008 2975 1771 1495 
SPBC4F6.13c -0.85 0.00008 10105 5695 5517 
lag1 -0.782 0.000088 5109 2937 3007 
tif11 -0.881 0.000091 14112 7781 7547 
swp1 -0.796 0.000094 5161 3190 2753 
SPCC126.01c -0.788 0.000094 5417 3206 3068 
hht1 -0.828 0.000097 10461 5530 6255 
SPNCRNA.460 -4.574 0.00011 26 0 2 
lsm2 -0.99 0.00011 1583 837 757 
SPBC30B4.09 -2.004 0.00012 1575 528 258 
SPAC1A6.10 -0.808 0.00012 6869 4198 3649 
rps602 -0.814 0.00013 9699 5237 5797 
pdx1 -0.825 0.00014 9512 5523 5215 
SPCC14G10.02 -0.786 0.00015 6606 3947 3716 
adg1 -1.197 0.00018 1834 673 927 
SPAC637.09 -0.764 0.00018 5954 3510 3501 
SPNCRNA.1626 -0.828 0.00019 13094 7071 7682 
SPCC1450.03 -0.746 0.0002 4727 2750 2888 
lys7 -1.102 0.00021 900 459 380 
SPAC1687.07 -1.054 0.00021 996 465 494 
SPBC713.04c -0.799 0.00021 9389 5386 5405 
SPCC18.17c -0.776 0.00021 3441 2023 1996 
isp7 -0.763 0.00021 4353 2734 2393 
SPAC11D3.11c -0.936 0.00023 1506 731 845 
SPBC839.03c -0.891 0.00023 1931 1035 1048 
mrpl7 -0.799 0.00023 3003 1759 1692 
  
69 
69 
SPBC21C3.19 -0.771 0.00023 3362 1952 1988 
SPAC18B11.06 -0.763 0.00023 3261 1794 2049 
pho4 -1.136 0.00026 45113 20518 20525 
git3 -0.741 0.00026 4114 2450 2473 
SPBP4H10.14c -0.799 0.00029 2837 1660 1601 
prs5 -0.871 0.00031 2147 1273 1074 
rds1 -0.861 0.00035 2082 1182 1111 
ubp12 -0.776 0.00035 9290 5380 5469 
erg31 -0.746 0.00036 3866 2436 2174 
ser2 -0.732 0.00036 3830 2272 2340 
rhp42 -0.803 0.00039 2568 1463 1482 
set10 -0.725 0.00044 5273 3268 3111 
SPBC3H7.05c -0.75 0.00051 9299 5212 5845 
SPNCRNA.1297 -1.193 0.00054 450 181 212 
vma7 -0.758 0.00059 8669 5324 4930 
obr1 -0.711 0.00059 4281 2397 2837 
SPBC1652.02 -0.72 0.00061 7341 4167 4750 
SPBC215.11c -0.94 0.00062 1325 742 640 
SPAC823.09c -0.897 0.00062 1525 840 797 
SPBC776.08c -0.738 0.00066 7655 4705 4476 
SPAC26A3.17c -0.769 0.00067 10939 6644 6196 
mug64 -0.733 0.00069 8764 5005 5545 
mpc2 -0.702 0.00071 4986 3132 2998 
SPBC409.08 -0.705 0.00072 5531 3455 3330 
sal3 -0.819 0.00073 19645 9994 12277 
SPAC11D3.14c -0.776 0.00073 2504 1462 1464 
SPNCRNA.1644 -0.748 0.00074 2754 1586 1694 
gmh6 -0.732 0.00077 7199 4608 4061 
has1 -0.742 0.0008 10467 6066 6448 
SPCC188.10c -1.005 0.00082 863 439 420 
  
70 
70 
avt5 -0.971 0.00082 1081 603 500 
SPAC29A4.03c -0.77 0.00087 11658 7371 6302 
SPBC244.02c -0.701 0.00094 3671 2313 2204 
SPBC23G7.13c -0.909 0.001 1162 584 654 
srb11 -0.943 0.0011 986 489 537 
SPNCRNA.863 -0.7 0.0011 6770 4238 4094 
agn2 -0.866 0.0012 1425 789 775 
SPAC1B2.03c -0.702 0.0012 6753 4334 3968 
new25 -0.834 0.0013 1549 851 887 
SPBC29A3.11c -0.737 0.0013 2662 1620 1573 
rpc19 -0.723 0.0013 2697 1582 1685 
trl1 -0.68 0.0013 6119 3825 3812 
ght8 -0.886 0.0014 27833 15152 14971 
laf1 -0.825 0.0014 1776 1087 917 
qcr7 -0.774 0.0014 15667 9459 8860 
rps902 -0.668 0.0014 4456 2840 2769 
sgp1 -0.74 0.0016 2563 1608 1461 
rga5 -0.729 0.0017 2694 1729 1520 
gln1 -0.704 0.0017 8666 5399 5242 
SPBC1683.04 -0.703 0.0017 2713 1576 1758 
cat1 -0.655 0.0018 4857 3096 3075 
SPNCRNA.329 -2.135 0.002 56 9 17 
SPNCRNA.1690 -0.815 0.002 1580 927 869 
SPBC17D1.01 -0.743 0.002 14188 8752 8207 
rpl101 -0.782 0.0022 5503 3517 2882 
rps001 -0.785 0.0023 20915 11797 12483 
SPCC737.05 -0.776 0.0023 2214 1419 1164 
SPAC23G3.05c -0.686 0.0023 2695 1571 1779 
ppk32 -0.668 0.0023 3311 2120 2048 
hsk1 -0.632 0.0023 3768 2239 2624 
  
71 
71 
SPAC637.08 -0.74 0.0024 3323 2174 1803 
SPAC30D11.11 -0.671 0.0024 7035 4570 4269 
SPAC11D3.02c -0.663 0.0024 6613 4285 4066 
SPAC16C9.02c -0.657 0.0024 5916 3881 3624 
las1 -0.655 0.0025 3284 2053 2117 
rpl1602 -1.246 0.0026 80807 34934 33223 
rrp46 -1.096 0.0027 9775 5294 3852 
rps402 -0.761 0.0027 19758 11084 12240 
klf1 -0.706 0.0027 2633 1719 1508 
SPAC7D4.03c -0.652 0.0027 5141 3523 3020 
SPNCRNA.1055 -1.55 0.0028 112 31 46 
SPBC29A3.06 -0.663 0.0028 8647 5214 5712 
SPAC2C4.12c -0.65 0.0028 3885 2642 2310 
SPBC2A9.06c -0.642 0.0028 3578 2285 2302 
prl53 -2.727 0.0029 32 6 3 
SPBC887.17 -0.792 0.0029 23719 13043 14360 
scp1 -0.689 0.0029 10177 6582 6039 
nic1 -0.65 0.0029 3662 2470 2195 
mis16 -0.636 0.0029 4259 2836 2644 
SPAC688.16 -0.79 0.003 1542 911 871 
mmi1 -0.637 0.003 6103 3862 3987 
gut2 -0.746 0.0032 2064 1340 1121 
SPNCRNA.604 -1.871 0.0033 70 22 16 
mdm10 -0.925 0.0033 732 377 394 
krp1 -0.655 0.0033 7432 4806 4633 
txl1 -0.634 0.0033 4089 2784 2484 
SPBC359.01 -0.87 0.0035 954 518 526 
SPAC821.05 -0.678 0.0035 9752 6412 5778 
mdl1 -0.652 0.0036 7116 4738 4321 
ptf1 -0.616 0.0036 3830 2432 2565 
  
72 
72 
SPNCRNA.1435 -0.928 0.0037 661 327 368 
SPAC222.08c -0.66 0.0037 8357 5418 5159 
rpc40 -0.612 0.0038 5309 3359 3588 
SPNCRNA.218 -1.589 0.0039 95 24 39 
SPNCRNA.1308 -1.581 0.0039 96 24 40 
SPBPB7E8.01 -0.758 0.0039 20613 12334 12050 
imt1 -0.748 0.0039 1731 1059 1002 
rpl402 -0.775 0.004 24316 13421 14995 
fip1 -0.704 0.004 2053 1218 1304 
rpl1902 -1.279 0.0041 98097 36001 44872 
SPBC15C4.04c -0.705 0.0041 11472 7685 6389 
SPBP16F5.06 -0.615 0.0041 4529 3047 2865 
SPAC1093.05 -0.65 0.0042 10080 6159 6687 
SPNCRNA.1087 -0.915 0.0046 672 352 361 
rpl301 -0.869 0.0046 32919 19757 16279 
SPBC1711.15c -0.74 0.0046 1580 903 990 
idi1 -0.614 0.0046 6529 4092 4439 
mug73 -1.394 0.0048 136 50 53 
vba2 -0.596 0.0048 3938 2503 2708 
tom40 -0.609 0.005 6770 4208 4667 
SPCC18.05c -0.585 0.005 4239 2623 3031 
SPNCRNA.1444 -1.429 0.0051 131 56 40 
SPAC212.12 -1.375 0.0051 692 329 204 
trm11 -0.613 0.0051 3409 2241 2217 
SPBC1683.03c -0.629 0.0052 2859 1798 1900 
mot1 -0.721 0.0055 19087 11671 11483 
dis3 -0.669 0.0055 13172 8369 8194 
SPAC890.04c -0.615 0.0056 7175 4608 4764 
fio1 -0.603 0.0056 6775 4241 4681 
ura3 -0.653 0.0057 12824 7786 8529 
  
73 
73 
SPAC513.07 -0.597 0.0057 4784 3232 3093 
SPBC530.15c -0.585 0.0058 4490 2923 3063 
moc3 -0.658 0.0062 2395 1543 1491 
SPBC691.04 -0.591 0.0062 6082 3871 4204 
per1 -0.611 0.0063 3037 1958 2020 
ssr2 -0.59 0.0063 4598 3116 2994 
SPAC959.06c -0.991 0.0064 411 197 217 
rcd1 -0.655 0.0064 2447 1602 1507 
plg7 -0.64 0.0064 2395 1451 1625 
SPBC4.02c -0.615 0.0065 7289 4887 4630 
SPCC18.02 -0.606 0.0065 3053 1964 2050 
cis4 -0.586 0.0065 4838 3242 3205 
rnp24 -0.578 0.0065 5290 3379 3709 
tim50 -0.574 0.0065 4316 2764 3035 
pfl7 -1.474 0.0066 103 34 40 
jmj4 -0.714 0.0066 1764 1142 1009 
SPCC1682.08c -0.604 0.0066 3210 2128 2095 
SPAC1399.04c -0.818 0.0068 952 551 528 
rib4 -0.739 0.0068 1352 775 846 
hhf3 -0.586 0.0069 6254 3981 4354 
mug111 -0.639 0.0072 2360 1466 1565 
SPAC3H1.06c -0.582 0.0072 4054 2755 2663 
mal1 -0.681 0.0073 1836 1112 1180 
mcl1 -0.587 0.0073 3723 2542 2413 
SPNCRNA.1097 -0.832 0.0074 870 509 468 
SPBC1347.13c -0.802 0.0076 960 549 553 
snd1 -0.577 0.0077 5228 3511 3497 
sum3 -0.872 0.008 40380 21971 22164 
urb2 -0.619 0.008 10632 6781 7061 
rps1701 -0.78 0.0081 1414 726 922 
  
74 
74 
nem1 -0.691 0.0081 1807 1172 1065 
SPAC2F3.11 -0.571 0.0083 4279 2918 2842 
SPBC3B8.08 -0.646 0.0084 2136 1322 1408 
arx1 -0.603 0.0084 3092 2137 1934 
fur4 -0.673 0.0085 2457 1684 1396 
ire1 -0.589 0.0086 3311 2269 2134 
SPBC15C4.02 -0.578 0.0089 5593 3837 3658 
SPNCRNA.1318 -0.722 0.009 1276 719 829 
vrs2 -0.579 0.0091 4391 3163 2713 
SPCC613.01 -0.662 0.0092 2139 1451 1252 
spb70 -0.572 0.0098 3452 2332 2312 
bgl2 -0.76 0.01 1002 557 627 
SPNCRNA.762 -0.746 0.01 1120 652 684 
isp4 -0.659 0.01 1831 1128 1191 
gpd2 -0.637 0.01 15798 9591 10722 
SPAC23H4.15 -0.618 0.01 12087 7769 7984 
dbp7 -0.595 0.01 2732 1780 1838 
SPBC3H7.02 -0.593 0.01 9899 6173 6952 
utp15 -0.569 0.01 6224 4118 4274 
SPAC1071.03c -0.565 0.01 5171 3580 3409 
snR93 -1.475 0.011 88 31 32 
ght5 -0.721 0.011 24975 15028 15278 
SPBC17A3.02 -0.677 0.011 1579 960 1016 
rrs1 -0.677 0.011 1568 942 1020 
taf6 -0.588 0.011 9516 6150 6509 
skb15 -0.569 0.011 3281 2246 2178 
SPBC30D10.07c -0.568 0.011 6358 4235 4342 
ckb2 -0.55 0.011 3891 2574 2742 
snR88 -2.178 0.012 33 5 10 
SPNCRNA.119 -1.329 0.012 121 55 41 
  
75 
75 
SPNCRNA.710 -0.963 0.012 347 171 185 
SPAC806.11 -0.961 0.012 395 223 182 
SPBC15D4.13c -0.949 0.012 397 216 196 
rps1902 -0.72 0.012 5165 3465 2803 
SPCC126.12 -0.627 0.012 2152 1408 1379 
SPCC736.03c -0.561 0.012 3608 2557 2332 
SPAC9G1.05 -0.558 0.012 6880 4400 4945 
SPCC11E10.07c -0.554 0.012 6040 3993 4233 
SPCC320.03 -0.539 0.012 4669 3044 3384 
SPNCRNA.664 -1.298 0.013 125 58 43 
SPBC2G5.04c -0.59 0.013 2780 1927 1765 
ppc1 -0.577 0.013 3017 2117 1925 
SPCC1259.08 -0.577 0.013 8889 5809 6109 
hmg1 -0.569 0.013 7668 5107 5232 
SPNCRNA.564 -1.61 0.014 61 14 26 
SPNCRNA.771 -0.722 0.014 1042 597 666 
SPAC2F3.05c -0.705 0.014 1228 740 766 
utp10 -0.694 0.014 23085 14558 13986 
prs1 -0.605 0.014 12127 8157 7794 
SPAC4G8.07c -0.585 0.014 2491 1619 1703 
SPBC1703.03c -0.571 0.014 8333 5568 5652 
sof1 -0.553 0.014 5588 3914 3701 
SPNCRNA.1599 -0.814 0.015 988 487 638 
SPNCRNA.1417 -0.759 0.015 912 557 520 
SPAC23H4.16c -0.648 0.015 1717 1134 1057 
rrp12 -0.632 0.015 18278 11078 12509 
imt3 -0.608 0.015 2233 1506 1423 
tea3 -0.595 0.015 9818 7001 5999 
SPCC18B5.08c -0.579 0.015 2590 1726 1742 
los1 -0.569 0.015 8253 5624 5504 
  
76 
76 
cig1 -0.562 0.015 3602 2635 2243 
trm112 -0.557 0.015 3045 2087 2053 
SPAC823.08c -0.546 0.015 3367 2314 2297 
efc25 -0.536 0.015 4482 3120 3060 
lys4 -1.006 0.016 15458 8989 6407 
SPCC1884.01 -0.932 0.016 335 168 184 
SPAC664.12c -0.62 0.016 1783 1113 1207 
hta1 -0.581 0.016 9960 6911 6403 
ely5 -0.572 0.016 2624 1764 1766 
SPBC1718.04 -0.56 0.016 3264 2367 2061 
SPCPB16A4.05c -0.546 0.016 3708 2730 2347 
mse1 -0.541 0.016 3971 2863 2595 
mug184 -0.537 0.016 4472 3223 2941 
fma1 -0.532 0.016 5155 3553 3576 
atg16 -0.817 0.017 647 404 330 
rep1 -0.749 0.017 867 530 502 
cpc2 -0.674 0.017 22895 14397 14312 
SPNCRNA.1319 -0.67 0.017 1208 690 829 
btb2 -0.643 0.017 1780 1239 1040 
orc5 -0.613 0.017 2032 1364 1292 
SPCC1259.02c -0.594 0.017 13157 8818 8617 
SPBC3H7.11 -0.575 0.017 2582 1771 1696 
SPBC215.01 -0.575 0.017 8499 6084 5329 
SPCC553.12c -0.571 0.017 2657 1844 1733 
SPAC1751.04 -0.57 0.017 2741 1914 1776 
SPAC1039.06 -0.561 0.017 2924 2063 1899 
msa1 -0.556 0.017 2820 1902 1936 
erg2 -0.553 0.017 3156 2260 2042 
SPAC1399.02 -0.552 0.017 2666 1711 1926 
ddb1 -0.551 0.017 7446 5100 5064 
  
77 
77 
gpi7 -0.533 0.017 4390 3169 2898 
SPCC18.13 -0.518 0.017 3502 2267 2625 
SPNCRNA.1333 -2.252 0.018 28 5 7 
SPCC16A11.01 -0.734 0.018 6562 4390 3499 
aim22 -0.648 0.018 1541 1010 955 
erg12 -0.631 0.018 1871 1317 1097 
SPAC29A4.13 -0.603 0.018 2142 1483 1336 
SPAC11D3.08c -0.583 0.018 2300 1561 1508 
SPBC56F2.08c -0.581 0.018 12244 8207 8165 
SPAC1786.02 -0.556 0.018 9733 6342 6899 
SPNCRNA.438 -0.728 0.019 1016 675 551 
SPAC17A2.02c -0.561 0.019 10385 6906 7172 
SPBC1A4.09 -0.56 0.019 8305 5919 5348 
SPCC613.07 -0.543 0.019 2886 1962 2001 
nrd1 -0.541 0.019 3075 2166 2059 
SPAC1B2.06 -0.928 0.02 304 156 163 
ppr6 -0.643 0.02 1555 1053 937 
arg5 -0.597 0.02 15214 10158 9961 
SPAC22E12.01 -0.591 0.02 1953 1238 1357 
rps901 -0.561 0.02 10126 6938 6787 
gpt2 -0.523 0.02 3583 2567 2418 
SPBC16E9.10c -0.502 0.02 4541 3031 3384 
SPAC589.05c -0.654 0.021 1356 870 854 
set13 -0.608 0.021 1820 1227 1160 
dbp2 -0.591 0.021 16995 10440 12130 
SPAC12G12.09 -0.53 0.021 3194 2251 2171 
cdc45 -0.524 0.021 6229 4315 4349 
erd2 -0.52 0.021 3809 2766 2547 
tom20 -0.746 0.022 14056 7318 9450 
SPBC18H10.18c -0.695 0.022 1153 781 642 
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SPCC777.17c -0.642 0.022 1306 800 874 
eng1 -0.635 0.022 12286 7089 8731 
rng3 -0.601 0.022 1889 1278 1211 
rps802 -0.579 0.022 13984 9396 9330 
grc3 -0.513 0.022 4844 3502 3283 
SPBC1604.06c -0.508 0.022 3534 2423 2548 
nxt1 -0.683 0.023 1148 765 664 
kap114 -0.513 0.023 5540 3915 3850 
SPCC191.05c -0.754 0.024 670 401 394 
rpa2 -0.586 0.024 15750 10460 10521 
rpb8 -0.548 0.024 5881 4355 3690 
trp3 -0.511 0.024 5687 3996 3988 
SPAC144.12 -0.502 0.024 5664 3862 4136 
SPNCRNA.431 -0.974 0.025 226 111 119 
SPNCRNA.1358 -0.828 0.025 1732 1110 841 
glt1 -0.78 0.025 42108 24134 24898 
mmd1 -0.565 0.026 1980 1280 1397 
esf1 -0.54 0.026 10960 7279 7800 
SPAC24H6.11c -0.521 0.026 6247 4578 4127 
lsb5 -0.505 0.026 4073 3020 2717 
rpl44 -0.599 0.027 17085 11761 10795 
SPCC584.01c -0.579 0.027 16250 10666 11094 
SPBC17D1.05 -0.571 0.027 14094 9769 9211 
erg28 -0.56 0.027 12991 8906 8718 
tim44 -0.556 0.027 12448 8512 8425 
utp25 -0.531 0.027 6345 4744 4034 
cog3 -0.512 0.027 3666 2770 2370 
SPMITTRNACYS.01 -3.169 0.028 14 1 2 
tam6 -1.224 0.028 110 58 36 
SPAC17G6.11c -0.543 0.028 8656 6424 5460 
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res1 -0.523 0.028 2861 2048 1932 
rax2 -0.518 0.028 7024 5055 4753 
SPCC4G3.17 -0.513 0.028 5566 4203 3596 
SPAC6F6.13c -0.796 0.029 7349 3628 4841 
rps101 -0.738 0.029 38868 21957 24658 
gpi14 -0.662 0.029 4122 2881 2329 
SPAC31A2.10 -0.561 0.029 2252 1623 1428 
SPNCRNA.1458 -1.009 0.03 202 118 82 
rps3 -0.825 0.03 53075 28102 31812 
pyp3 -0.682 0.03 959 625 570 
SPBC418.02 -0.55 0.03 2179 1499 1477 
etp1 -0.525 0.03 9003 6305 6205 
skb1 -0.514 0.03 7841 5479 5502 
rps1501 -0.508 0.03 6152 4522 4132 
SPAC18B11.11 -0.505 0.03 3583 2701 2346 
SPAC343.13 -0.693 0.031 879 572 515 
hem15 -0.645 0.031 1189 799 721 
ubc14 -0.632 0.031 1393 987 810 
SPAC823.07 -0.623 0.031 1466 1039 862 
lcf2 -0.635 0.032 24863 15935 16077 
moe1 -0.531 0.032 11037 7634 7640 
mdm28 -0.526 0.032 10456 7258 7268 
mrp17 -0.521 0.032 2535 1764 1768 
rps401 -0.894 0.033 63663 35781 32725 
SPNCRNA.1092 -0.893 0.034 237 108 147 
cwf24 -0.559 0.034 1780 1160 1257 
SPBP22H7.02c -0.51 0.034 7720 5557 5283 
mpg1 -0.51 0.034 8338 5846 5866 
SPAC2C4.06c -0.506 0.034 2639 1805 1913 
SPNCRNA.197 -1.565 0.035 47 14 18 
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abh1 -0.513 0.035 2814 2076 1866 
SPNCRNA.1298 -1.328 0.036 73 31 26 
fub2 -0.864 0.036 5325 3372 2480 
SPBC4B4.04 -0.52 0.036 10602 7426 7362 
SPCC70.03c -0.51 0.036 8277 5943 5680 
meu34 -0.503 0.037 2914 2154 1958 
SPNCRNA.861 -0.879 0.038 279 162 141 
sen2 -0.609 0.038 1400 999 836 
SPAC890.05 -0.593 0.038 9109 5411 6665 
SPNCRNA.1352 -0.813 0.039 412 267 202 
SPCC757.05c -0.57 0.039 1697 1191 1095 
cif1 -0.532 0.039 2096 1318 1583 
uvi15 -0.505 0.039 7553 5635 5008 
SPBC1683.06c -0.713 0.04 624 391 370 
ter1 -0.653 0.04 3060 2158 1732 
otu1 -0.519 0.04 2263 1582 1576 
SPAC328.09 -0.534 0.041 2746 2059 1731 
SPAPB24D3.06c -0.534 0.041 1927 1300 1361 
SPAP11E10.01 -0.517 0.041 2313 1640 1591 
new12 -0.962 0.042 179 74 110 
SPCC4B3.02c -0.669 0.042 891 611 509 
dbp3 -0.573 0.042 14630 8837 10832 
SPAC11D3.06 -0.572 0.042 1389 884 984 
arg3 -0.562 0.042 6068 4490 3732 
SPAC25B8.06c -0.535 0.042 2205 1635 1407 
SPBC776.06c -0.502 0.042 2649 1936 1802 
rrg9 -0.964 0.043 560 339 235 
imt2 -0.762 0.043 441 263 257 
tsc2 -0.505 0.043 10005 7176 6926 
SPNCRNA.423 -1.105 0.044 116 61 46 
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SPCC569.03 -0.608 0.044 1027 624 724 
rpl1502 -0.592 0.044 22947 15133 15309 
git5 -0.585 0.044 1378 944 893 
abc2 -0.54 0.044 16589 11106 11719 
yrs1 -0.515 0.044 11712 8384 8011 
SPNCRNA.911 -1.12 0.045 100 41 51 
SPAC8E11.01c -0.575 0.045 1416 962 939 
rpl502 -0.503 0.045 12959 8559 9729 
mfs1 -0.7 0.046 5013 2682 3492 
elf1 -0.553 0.046 17242 12123 11377 
SPNCRNA.1602 -0.629 0.047 1034 717 620 
SPBP23A10.06 -0.591 0.047 1321 936 818 
ibp1 -0.568 0.047 1625 1199 992 
cti1 -0.518 0.047 2278 1702 1479 
clr2 -0.514 0.047 2089 1448 1477 
SPNCRNA.1207 -2.139 0.049 21 5 5 
meu29 -0.559 0.049 1476 1004 1000 
rpl2101 -0.546 0.049 1753 1265 1136 
SPNCRNA.953 -0.539 0.049 1673 1149 1155 
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Supplementary Table 4. Gene list analysis of the 382 up-regulated genes in the slow 
mutant 
 
Category_Nam
e 
GeneSet_Name over_represented 
under_represented 
List_Frequency Background_Frequenc
y 
Corrected_pvalu
e 
GO Biological 
Process 
pheromone-dependent signal 
transduction involved in 
conjugation with cellular 
fusion 
Enriched 2.094240838 
(8/382) 
0.271234832 
(19/7005) 
0.00121184 
GO Biological 
Process 
signal transduction involved in 
conjugation with cellular 
fusion 
Enriched 2.094240838 
(8/382) 
0.299785867 
(21/7005) 
0.00245112 
GO Biological 
Process 
response to pheromone Enriched 2.356020942 
(9/382) 
0.428265525 
(30/7005) 
0.00498635 
GO Biological 
Process 
cellular response to pheromone Enriched 2.356020942 
(9/382) 
0.428265525 
(30/7005) 
0.00498635 
GO Biological 
Process 
G-protein coupled receptor 
signaling pathway 
Enriched 2.094240838 
(8/382) 
0.356887937 
(25/7005) 
0.00725759 
Gene Expression Reproduction module Enriched 14.65968586 
(56/382) 
4.225553176 
(296/7005) 
9.74595E-14 
Gene Expression Core Environmental Stress 
Response induced 
Enriched 19.89528796 
(76/382) 
7.723054961 
(541/7005) 
4.90506E-12 
Gene Expression Oxidative Stess Cluster 4 Enriched 16.4921466 
(63/382) 
5.91006424 
(414/7005) 
3.01199E-11 
Gene Expression Stress module Enriched 8.90052356 
(34/382) 
1.941470378 
(136/7005) 
3.01199E-11 
Gene Expression Nitrogen depletion total 
meiotic genes 
Enriched 10.47120419 
(40/382) 
3.01213419 
(211/7005) 
2.04581E-09 
Gene Expression Nitrogen depletion continuous 
meiotic genes 
Enriched 5.497382199 
(21/382) 
0.985010707 
(69/7005) 
4.12461E-08 
Gene Expression Meiosis sporulation module Enriched 10.73298429 
(41/382) 
3.882940757 
(272/7005) 
1.25823E-06 
Gene Expression Nitrogen depletion delayed 
meiotic genes 
Enriched 3.664921466 
(14/382) 
0.542469665 
(38/7005) 
3.27646E-06 
Gene Expression Early meiotic genes Enriched 5.759162304 
(22/382) 
1.399000714 
(98/7005) 
5.47663E-06 
Gene Expression Induced rnc1 mutant Enriched 4.45026178 
(17/382) 
1.099214847 
(77/7005) 
0.000315512 
Gene Expression Ste11 targets Enriched 3.926701571 
(15/382) 
0.885082084 
(62/7005) 
0.000356055 
Gene Expression Induced pan3 mutant Enriched 2.617801047 
(10/382) 
0.428265525 
(30/7005) 
0.000951126 
Gene Expression Induced Dbr1 deletion Enriched 10.47120419 
(40/382) 
4.925053533 
(345/7005) 
0.00154587 
Gene Expression Caffeine and Rapamycin 
induced 
Enriched 9.42408377 
(36/382) 
4.339757316 
(304/7005) 
0.00245112 
Gene Expression Induced mug187 mutant Enriched 3.403141361 
(13/382) 
0.827980014 
(58/7005) 
0.00297469 
Gene Expression Sty1 but not Atf1 activated 
genes 
Enriched 2.617801047 
(10/382) 
0.499643112 
(35/7005) 
0.00302965 
  
83 
83 
Gene Expression Respiration module Enriched 2.879581152 
(11/382) 
0.670949322 
(47/7005) 
0.00708287 
Phenotypes 
(FYPO) 
inviable cell Underrepresented 12.30366492 
(47/382) 
22.21270521 
(1556/7005) 
0.000290173 
Phenotypes 
(FYPO) 
abnormal cellular component 
organization during vegetative 
growth 
Underrepresented 4.97382199 
(19/382) 
12.54817987 
(879/7005) 
0.000336326 
Phenotypes 
(FYPO) 
inviable cell population Underrepresented 11.78010471 
(45/382) 
21.4703783 
(1504/7005) 
0.000337576 
Phenotypes 
(FYPO) 
inviable vegetative cell 
population 
Underrepresented 11.78010471 
(45/382) 
21.27052106 
(1490/7005) 
0.000402918 
Phenotypes 
(FYPO) 
abnormal cellular physical 
quality phenotype during 
vegetative growth 
Underrepresented 17.80104712 
(68/382) 
28.17987152 
(1974/7005) 
0.000819663 
Phenotypes 
(FYPO) 
inviable vegetative cell Underrepresented 10.9947644 
(42/382) 
19.85724483 
(1391/7005) 
0.000980878 
Phenotypes 
(FYPO) 
abnormal cellular physical 
quality phenotype 
Underrepresented 24.86910995 
(95/382) 
35.63169165 
(2496/7005) 
0.00157609 
Phenotypes 
(FYPO) 
abnormal vegetative cell 
morphology 
Underrepresented 9.162303665 
(35/382) 
17.0592434 
(1195/7005) 
0.00275584 
Phenotypes 
(FYPO) 
abnormal subcellular 
component during vegetative 
growth 
Underrepresented 5.759162304 
(22/382) 
12.54817987 
(879/7005) 
0.00297469 
Phenotypes 
(FYPO) 
abnormal cell morphology Underrepresented 15.70680628 
(60/382) 
24.62526767 
(1725/7005) 
0.00466407 
Phenotypes 
(FYPO) 
abnormal microtubule 
cytoskeleton organization 
Underrepresented 0.785340314 
(3/382) 
4.568165596 
(320/7005) 
0.00559735 
Phenotypes 
(FYPO) 
microtubule cytoskeleton 
organization phenotype 
Underrepresented 0.785340314 
(3/382) 
4.568165596 
(320/7005) 
0.00559735 
Phenotypes 
(FYPO) 
inviable after spore 
germination 
Underrepresented 5.497382199 
(21/382) 
11.77730193 
(825/7005) 
0.00620368 
Phenotypes 
(FYPO) 
abnormal microtubule 
cytoskeleton organization 
during vegetative growth 
Underrepresented 0.785340314 
(3/382) 
4.468236974 
(313/7005) 
0.00725759 
Phenotypes 
(FYPO) 
abnormal regulation of 
conjugation 
Enriched 2.356020942 
(9/382) 
0.471092077 
(33/7005) 
0.00889607 
Phenotypes 
(FYPO) 
abnormal response to 
pheromone 
Enriched 2.356020942 
(9/382) 
0.471092077 
(33/7005) 
0.00889607 
Phenotypes 
(FYPO) 
abnormal transcriptional 
response to pheromone 
Enriched 2.094240838 
(8/382) 
0.371163455 
(26/7005) 
0.00893103 
Phenotypes 
(FYPO) 
abnormal vegetative cell shape Underrepresented 8.376963351 
(32/382) 
15.28907923 
(1071/7005) 
0.00962284 
Protein Features Number of amino acids Lower 318.0326087 472.655967078189 2.26504E-15 
Protein Features Molecular weight (kDa) Lower 36.01722319 53.3015431975308 2.39132E-15 
Protein Features Protein Half Life (minutes) Lower 649.02 819.946483398785 0.00157609 
Protein Features Homo sapiens orthologs Underrepresented 39.790575916230
4 (152/382) 
50.321199143469 
(3525/7005) 
0.00559735 
Protein Features Lysine Higher 0.074423535 0.067540460267044 0.00868688 
Transcript 
Features 
Ribosomal density (rb/kb) Higher 7.229120718 4.38104237408602 2.26504E-15 
  
84 
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Transcript 
Features 
mRNA level (WT) Lower 2096.798866 2838.62971574337 7.41018E-08 
Transcript 
Features 
Annotated transcript length Lower 1516.701571 1879.33519553073 8.94839E-07 
Transcript 
Features 
Relative Pol II occupancy Lower 1.068941176 1.35469424460432 0.00820736 
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Supplementary Table 5. Gene list analysis of the 494 down-regulated genes in the slow 
mutant 
Category_Name GeneSet_Name over_represented 
under_represented 
List_Frequency Background 
Frequency 
Corrected_pvalue 
GO Biological 
Process 
ribosome biogenesis Enriched 15.1821862348178 
(75/494) 
5.4389721627409 
(381/7005) 
3.74905E-14 
GO Biological 
Process 
ribonucleoprotein 
complex biogenesis 
Enriched 15.587044534413 
(77/494) 
6.5524625267666 
(459/7005) 
1.10439E-10 
GO Biological 
Process 
ncRNA metabolic 
process 
Enriched 13.5627530364372 
(67/494) 
5.72448251249108 
(401/7005) 
5.10987E-09 
GO Biological 
Process 
rRNA processing Enriched 9.31174089068826 
(46/494) 
3.32619557458958 
(233/7005) 
3.09853E-08 
GO Biological 
Process 
biological process Enriched 87.246963562753 
(431/494) 
75.8315488936474 
(5312/7005) 
3.32409E-08 
GO Biological 
Process 
transmembrane 
transport 
Enriched 11.336032388664 
(56/494) 
4.53961456102784 
(318/7005) 
4.18638E-08 
GO Biological 
Process 
rRNA metabolic 
process 
Enriched 9.31174089068826 
(46/494) 
3.42612419700214 
(240/7005) 
7.51368E-08 
GO Biological 
Process 
ncRNA processing Enriched 11.1336032388664 
(55/494) 
4.85367594575303 
(340/7005) 
8.91026E-07 
GO Biological 
Process 
nitrogen compound 
transport 
Enriched 6.47773279352227 
(32/494) 
2.12705210563883 
(149/7005) 
2.19708E-06 
GO Biological 
Process 
cellular process Enriched 72.6720647773279 
(359/494) 
62.2698072805139 
(4362/7005) 
9.33389E-05 
GO Biological 
Process 
anion transmembrane 
transport 
Enriched 4.04858299595142 
(20/494) 
1.25624553890079 
(88/7005) 
0.000340978 
GO Biological 
Process 
amino acid transport Enriched 2.42914979757085 
(12/494) 
0.499643112062812 
(35/7005) 
0.000389761 
GO Biological 
Process 
anion transport Enriched 4.8582995951417 
(24/494) 
1.74161313347609 
(122/7005) 
0.000489245 
GO Biological 
Process 
amino acid 
transmembrane 
transport 
Enriched 2.22672064777328 
(11/494) 
0.442541042112777 
(31/7005) 
0.000635175 
GO Biological 
Process 
organelle fission Underrepresented 1.61943319838057 
(8/494) 
5.7530335474661 
(403/7005) 
0.000663542 
GO Biological 
Process 
import into cell Enriched 2.22672064777328 
(11/494) 
0.456816559600286 
(32/7005) 
0.000840391 
GO Biological 
Process 
import across plasma 
membrane 
Enriched 2.22672064777328 
(11/494) 
0.456816559600286 
(32/7005) 
0.000840391 
GO Biological 
Process 
nuclear division Underrepresented 1.61943319838057 
(8/494) 
5.65310492505353 
(396/7005) 
0.000856425 
GO Biological 
Process 
L-amino acid transport Enriched 1.61943319838057 
(8/494) 
0.242683797287652 
(17/7005) 
0.00102357 
GO Biological 
Process 
ribosomal small 
subunit biogenesis 
Enriched 4.25101214574899 
(21/494) 
1.48465381870093 
(104/7005) 
0.00111245 
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GO Biological 
Process 
L-arginine import Enriched 1.21457489878543 
(6/494) 
0.142755174875089 
(10/7005) 
0.00226528 
GO Biological 
Process 
arginine import Enriched 1.21457489878543 
(6/494) 
0.142755174875089 
(10/7005) 
0.00226528 
GO Biological 
Process 
L-arginine transport Enriched 1.21457489878543 
(6/494) 
0.142755174875089 
(10/7005) 
0.00226528 
GO Biological 
Process 
L-arginine 
transmembrane 
transport 
Enriched 1.21457489878543 
(6/494) 
0.142755174875089 
(10/7005) 
0.00226528 
GO Biological 
Process 
arginine 
transmembrane 
transport 
Enriched 1.21457489878543 
(6/494) 
0.142755174875089 
(10/7005) 
0.00226528 
GO Biological 
Process 
organic acid transport Enriched 2.63157894736842 
(13/494) 
0.699500356887937 
(49/7005) 
0.00255245 
GO Biological 
Process 
carboxylic acid 
transport 
Enriched 2.63157894736842 
(13/494) 
0.699500356887937 
(49/7005) 
0.00255245 
GO Biological 
Process 
organic acid 
transmembrane 
transport 
Enriched 2.42914979757085 
(12/494) 
0.613847251962884 
(43/7005) 
0.00299364 
GO Biological 
Process 
ion transmembrane 
transport 
Enriched 5.66801619433198 
(28/494) 
2.48394004282655 
(174/7005) 
0.00340289 
GO Biological 
Process 
maturation of SSU-
rRNA 
Enriched 3.4412955465587 
(17/494) 
1.14204139900071 
(80/7005) 
0.00341893 
GO Biological 
Process 
L-alpha-amino acid 
transmembrane 
transport 
Enriched 1.417004048583 
(7/494) 
0.214132762312634 
(15/7005) 
0.00344205 
GO Biological 
Process 
nitrogen compound 
metabolic process 
Enriched 35.2226720647773 
(174/494) 
27.1092077087794 
(1899/7005) 
0.00406228 
GO Biological 
Process 
arginine transport Enriched 1.21457489878543 
(6/494) 
0.157030692362598 
(11/7005) 
0.00406228 
GO Biological 
Process 
lysine import Enriched 1.21457489878543 
(6/494) 
0.157030692362598 
(11/7005) 
0.00406228 
GO Biological 
Process 
L-lysine import Enriched 1.21457489878543 
(6/494) 
0.157030692362598 
(11/7005) 
0.00406228 
GO Biological 
Process 
organic anion transport Enriched 3.4412955465587 
(17/494) 
1.17059243397573 
(82/7005) 
0.00436282 
GO Biological 
Process 
maturation of SSU-
rRNA from tricistronic 
rRNA transcript (SSU-
rRNA, 5.8S rRNA, 
LSU-rRNA) 
Enriched 2.63157894736842 
(13/494) 
0.756602426837973 
(53/7005) 
0.00547693 
GO Biological 
Process 
ion transport Enriched 6.47773279352227 
(32/494) 
3.14061384725196 
(220/7005) 
0.00715253 
GO Biological 
Process 
L-amino acid import Enriched 1.21457489878543 
(6/494) 
0.171306209850107 
(12/7005) 
0.00716438 
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GO Biological 
Process 
L-lysine 
transmembrane 
transport 
Enriched 1.21457489878543 
(6/494) 
0.171306209850107 
(12/7005) 
0.00716438 
GO Biological 
Process 
L-lysine import across 
plasma membrane 
Enriched 1.01214574898785 
(5/494) 
0.114204139900071 
(8/7005) 
0.00728083 
GO Biological 
Process 
L-lysine import into 
cell 
Enriched 1.01214574898785 
(5/494) 
0.114204139900071 
(8/7005) 
0.00728083 
GO Biological 
Process 
cell division Underrepresented 0.809716599190283 
(4/494) 
3.61170592433976 
(253/7005) 
0.00772314 
GO Biological 
Process 
organic cyclic 
compound metabolic 
process 
Enriched 32.5910931174089 
(161/494) 
25.0678087080657 
(1756/7005) 
0.00895515 
GO Biological 
Process 
single-organism 
organelle organization 
Underrepresented 7.69230769230769 
(38/494) 
13.1334760885082 
(920/7005) 
0.00895515 
GO Biological 
Process 
sphingolipid 
biosynthetic process 
Enriched 1.61943319838057 
(8/494) 
0.328336902212705 
(23/7005) 
0.00946184 
GO Biological 
Process 
organonitrogen 
compound metabolic 
process 
Enriched 12.1457489878543 
(60/494) 
7.43754461099215 
(521/7005) 
0.00978697 
Gene Expression Caffeine and 
Rapamycin repressed 
Enriched 19.0283400809717 
(94/494) 
4.46823697359029 
(313/7005) 
8.44625E-33 
Gene Expression Core Environmental 
Stress Response 
repressed 
Enriched 21.8623481781377 
(108/494) 
6.26695217701642 
(439/7005) 
5.65706E-30 
Gene Expression Induced pat1.114 
mutant 
Enriched 14.3724696356275 
(71/494) 
5.39614561027837 
(378/7005) 
2.99277E-12 
Gene Expression Ribosomal protein 
module 2 
Enriched 10.3238866396761 
(51/494) 
3.82583868665239 
(268/7005) 
1.18206E-08 
Gene Expression Oxidative Stess Cluster 
6 
Enriched 7.48987854251012 
(37/494) 
2.5553176302641 
(179/7005) 
4.8973E-07 
Gene Expression Oxidative Stess Cluster 
10 
Enriched 3.84615384615385 
(19/494) 
0.870806566738044 
(61/7005) 
4.3927E-06 
Gene Expression htb1 brl1 brl2 set1 
mutant repressed 
Enriched 6.07287449392713 
(30/494) 
1.97002141327623 
(138/7005) 
4.44699E-06 
Gene Expression Ribosomal protein 
module Homol D E 
Enriched 7.69230769230769 
(38/494) 
3.16916488222698 
(222/7005) 
5.67231E-05 
Gene Expression Cell cycle periodically 
expressed 
Enriched 13.3603238866397 
(66/494) 
7.10920770877944 
(498/7005) 
7.61041E-05 
Gene Expression Repressed Dbr1 
deletion 
Enriched 7.48987854251012 
(37/494) 
3.32619557458958 
(233/7005) 
0.000397722 
Gene Expression Amino acid 
metabolism module 
Enriched 5.26315789473684 
(26/494) 
1.95574589578872 
(137/7005) 
0.000397722 
Gene Expression Oxidative Stess Cluster 
9 
Enriched 5.46558704453441 
(27/494) 
2.11277658815132 
(148/7005) 
0.000530375 
Gene Expression Cell Cycle Cluster 4 Enriched 5.66801619433198 
(28/494) 
2.26980728051392 
(159/7005) 
0.00068364 
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Gene Expression Oxidative Stess Cluster 
11 
Enriched 4.65587044534413 
(23/494) 
1.67023554603854 
(117/7005) 
0.000721882 
Gene Expression Induced SPAC17H9 
04c mutant 
Enriched 3.84615384615385 
(19/494) 
1.27052105638829 
(89/7005) 
0.00126594 
Gene Expression Repressed spt6 mutant Enriched 1.82186234817814 
(9/494) 
0.385438972162741 
(27/7005) 
0.0057658 
Phenotypes 
(FYPO) 
cell phenotype Enriched 86.8421052631579 
(429/494) 
70.5353319057816 
(4941/7005) 
2.70753E-15 
Phenotypes 
(FYPO) 
cell population 
viability 
Enriched 87.0445344129555 
(430/494) 
70.6780870806567 
(4951/7005) 
2.70753E-15 
Phenotypes 
(FYPO) 
phenotype Enriched 87.246963562753 
(431/494) 
71.0920770877944 
(4980/7005) 
3.2652E-15 
Phenotypes 
(FYPO) 
cell population 
phenotype 
Enriched 87.0445344129555 
(430/494) 
70.8636688079943 
(4964/7005) 
3.28059E-15 
Phenotypes 
(FYPO) 
cellular physical 
quality phenotype 
Enriched 86.2348178137652 
(426/494) 
70.0071377587438 
(4904/7005) 
5.58698E-15 
Phenotypes 
(FYPO) 
vegetative cell 
phenotype 
Enriched 85.0202429149798 
(420/494) 
68.8222698072805 
(4821/7005) 
1.46432E-14 
Phenotypes 
(FYPO) 
cellular physical 
quality phenotype 
during vegetative 
growth 
Enriched 84.6153846153846 
(418/494) 
68.3654532476802 
(4789/7005) 
1.46432E-14 
Phenotypes 
(FYPO) 
cell viability Enriched 85.2226720647773 
(421/494) 
69.5074946466809 
(4869/7005) 
7.15274E-14 
Phenotypes 
(FYPO) 
viable vegetative cell 
with normal cell 
morphology 
Enriched 56.6801619433198 
(280/494) 
44.4396859386153 
(3113/7005) 
4.12552E-06 
Phenotypes 
(FYPO) 
normal cell 
morphology 
Enriched 63.3603238866397 
(313/494) 
51.8058529621699 
(3629/7005) 
2.05356E-05 
Phenotypes 
(FYPO) 
normal vegetative cell 
morphology 
Enriched 63.3603238866397 
(313/494) 
51.7487508922198 
(3625/7005) 
2.05356E-05 
Phenotypes 
(FYPO) 
normal phenotype Enriched 68.2186234817814 
(337/494) 
57.3590292648108 
(4018/7005) 
6.37781E-05 
Phenotypes 
(FYPO) 
viable vegetative cell 
population 
Enriched 67.4089068825911 
(333/494) 
56.6595289079229 
(3969/7005) 
8.19659E-05 
Phenotypes 
(FYPO) 
viable vegetative cell Enriched 63.3603238866397 
(313/494) 
52.6338329764454 
(3687/7005) 
0.000121541 
Phenotypes 
(FYPO) 
viable cell population Enriched 67.4089068825911 
(333/494) 
56.859386152748 
(3983/7005) 
0.000122133 
Phenotypes 
(FYPO) 
viable cell Enriched 63.3603238866397 
(313/494) 
52.6909350463954 
(3691/7005) 
0.000144201 
Phenotypes 
(FYPO) 
normal vegetative 
phenotype 
Enriched 65.7894736842105 
(325/494) 
55.260528194147 
(3871/7005) 
0.000162494 
Phenotypes 
(FYPO) 
inviable after spore 
germination, without 
cell division 
Enriched 12.3481781376518 
(61/494) 
7.15203426124197 
(501/7005) 
0.00210857 
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Phenotypes 
(FYPO) 
inviable after spore 
germination, without 
cell division, with 
abnormal germ tube 
morphology 
Enriched 5.26315789473684 
(26/494) 
2.21270521056388 
(155/7005) 
0.00384578 
Phenotypes 
(FYPO) 
abnormal phenotype Enriched 64.7773279352227 
(320/494) 
56.4596716630978 
(3955/7005) 
0.00946184 
Protein Domains 
(Pfam) 
Amino acid permease Enriched 1.01214574898785 
(5/494) 
0.114204139900071 
(8/7005) 
0.00728083 
Protein Domains 
(Pfam) 
Major Facilitator 
Superfamily 
Enriched 2.42914979757085 
(12/494) 
0.685224839400428 
(48/7005) 
0.00787962 
Protein Features Glutamic acid Lower 0.0565112896113241 0.0660338227478138 8.25525E-11 
Protein Features Valine Higher 0.066415046214053 0.0602659980510806 1.17199E-09 
Protein Features S.cerevisiae orthologs Enriched 70.2429149797571 
(347/494) 
55.7744468236974 
(3907/7005) 
4.42542E-09 
Protein Features Asparagine Lower 0.0458489224721031 0.0510031960168226 1.61689E-07 
Protein Features Nitrogen content Lower 1.3483399811237 1.36731438301884 3.34215E-07 
Protein Features Glycine Higher 0.0569013300924529 0.0503929881606619 1.04756E-06 
Protein Features Lysine Lower 0.0620996791448227 0.0684520802522902 5.48698E-06 
Protein Features Glutamine Lower 0.0347078197667617 0.0385671177208081 3.57811E-05 
Protein Features Alanine Higher 0.0676338570719653 0.0629322969189161 7.91722E-05 
Protein Features Homo sapiens 
orthologs 
Enriched 61.1336032388664 
(302/494) 
50.321199143469 
(3525/7005) 
0.000121861 
Protein Features Tryptophan Higher 0.0130727202665548 0.011038781899495 0.000231345 
Protein Features Protein Half Life 
(minutes) 
Higher 956.527450980392 798.070886075947 0.000500445 
Transcript 
Features 
protein coding Enriched 88.663967611336 
(438/494) 
73.3190578158458 
(5136/7005) 
8.22262E-15 
Transcript 
Features 
mRNA copies per 
proliferating cell 
Lower 9.81348472505092 141.164213135048 2.73756E-12 
Transcript 
Features 
mRNA level Higher 3527.5093578199 2732.02169582478 1.27145E-09 
Transcript 
Features 
ncRNA level Underrepresented 10.3238866396761 
(51/494) 
21.8843683083512 
(1533/7005) 
2.51098E-09 
Transcript 
Features 
Top 20% shortest 
transcripts 
Underrepresented 9.7165991902834 
(48/494) 
20 (1401/7005) 7.39741E-08 
Transcript 
Features 
Top 10% shortest 
transcripts 
Underrepresented 3.4412955465587 
(17/494) 
9.99286224125625 
(700/7005) 
5.43852E-06 
Transcript 
Features 
Annotated transcript 
length 
Higher 2033.53036437247 1846.36046690217 2.53312E-05 
 
 
